Nutritional and exercise interventions in cancer-related cachexia: an extensive narrative review

One of the common traits found in cancer patients is malnutrition and cachexia, which affects between 25% to 60% of the patients, depending on the type of cancer, diagnosis, and treatment. Given the lack of current effective pharmacological solutions for low muscle mass and sarcopenia, holistic inte...

Full description

Autores:: Clemente-Suárez, Vicente Javier
Redondo-Flórez, Laura
Rubio-Zarapuz, Alejandro
Martínez-Guardado, Ismael
Navarro-Jiménez, Eduardo
Tornero-Aguilera, José Francisco

Tipo de recurso:: Article of investigation

Fecha de publicación:: 2022

Institución:: Corporación Universidad de la Costa

Repositorio:: REDICUC - Repositorio CUC

Idioma:: eng

id	RCUC2_f18f9c048fe970e4d567390beab11457
oai_identifier_str	oai:repositorio.cuc.edu.co:11323/10942
network_acronym_str	RCUC2
network_name_str	REDICUC - Repositorio CUC
repository_id_str
dc.title.eng.fl_str_mv	Nutritional and exercise interventions in cancer-related cachexia: an extensive narrative review
title	Nutritional and exercise interventions in cancer-related cachexia: an extensive narrative review
spellingShingle	Nutritional and exercise interventions in cancer-related cachexia: an extensive narrative review Cachexia Cancer Endurance training Ergonutritional Nutrition Physical activity Strength training
title_short	Nutritional and exercise interventions in cancer-related cachexia: an extensive narrative review
title_full	Nutritional and exercise interventions in cancer-related cachexia: an extensive narrative review
title_fullStr	Nutritional and exercise interventions in cancer-related cachexia: an extensive narrative review
title_full_unstemmed	Nutritional and exercise interventions in cancer-related cachexia: an extensive narrative review
title_sort	Nutritional and exercise interventions in cancer-related cachexia: an extensive narrative review
dc.creator.fl_str_mv	Clemente-Suárez, Vicente Javier Redondo-Flórez, Laura Rubio-Zarapuz, Alejandro Martínez-Guardado, Ismael Navarro-Jiménez, Eduardo Tornero-Aguilera, José Francisco
dc.contributor.author.none.fl_str_mv	Clemente-Suárez, Vicente Javier Redondo-Flórez, Laura Rubio-Zarapuz, Alejandro Martínez-Guardado, Ismael Navarro-Jiménez, Eduardo Tornero-Aguilera, José Francisco
dc.subject.proposal.eng.fl_str_mv	Cachexia Cancer Endurance training Ergonutritional Nutrition Physical activity Strength training
topic	Cachexia Cancer Endurance training Ergonutritional Nutrition Physical activity Strength training
description	One of the common traits found in cancer patients is malnutrition and cachexia, which affects between 25% to 60% of the patients, depending on the type of cancer, diagnosis, and treatment. Given the lack of current effective pharmacological solutions for low muscle mass and sarcopenia, holistic interventions are essential to patient care, as well as exercise and nutrition. Thus, the present narrative review aimed to analyze the nutritional, pharmacological, ergonutritional, and physical exercise strategies in cancer-related cachexia. The integration of multidisciplinary interventions could help to improve the final intervention in patients, improving their prognosis, quality of life, and life expectancy. To reach these aims, an extensive narrative review was conducted. The databases used were MedLine (PubMed), Cochrane (Wiley), Embase, PsychINFO, and CinAhl. Cancer-related cachexia is a complex multifactorial phenomenon in which systemic inflammation plays a key role in the development and maintenance of the symptomatology. Pharmacological interventions seem to produce a positive effect on inflammatory state and cachexia. Nutritional interventions are focused on a high-energy diet with high-density foods and the supplementation with antioxidants, while physical activity is focused on strength-based training. The implementation of multidisciplinary non-pharmacological interventions in cancer-related cachexia could be an important tool to improve traditional treatments and improve patients’ quality of life.
publishDate	2022
dc.date.issued.none.fl_str_mv	2022-04-11
dc.date.accessioned.none.fl_str_mv	2024-04-04T20:03:09Z
dc.date.available.none.fl_str_mv	2024-04-04T20:03:09Z
dc.type.spa.fl_str_mv	Artículo de revista
dc.type.coar.spa.fl_str_mv	http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.content.spa.fl_str_mv	Text
dc.type.driver.spa.fl_str_mv	info:eu-repo/semantics/article
dc.type.redcol.spa.fl_str_mv	http://purl.org/redcol/resource_type/ART
dc.type.version.spa.fl_str_mv	info:eu-repo/semantics/publishedVersion
dc.type.coarversion.spa.fl_str_mv	http://purl.org/coar/version/c_970fb48d4fbd8a85
format	http://purl.org/coar/resource_type/c_2df8fbb1
status_str	publishedVersion
dc.identifier.citation.spa.fl_str_mv	Clemente-Suárez, V.J.; Redondo-Flórez, L.; Rubio-Zarapuz, A.; Martínez-Guardado, I.; Navarro-Jiménez, E.; TorneroAguilera, J.F. Nutritional and Exercise Interventions in Cancer-Related Cachexia: An Extensive Narrative Review. Int. J. Environ. Res. Public Health 2022, 19, 4604. https://doi.org/10.3390/ijerph19084604
dc.identifier.issn.spa.fl_str_mv	1661-7827
dc.identifier.uri.none.fl_str_mv	https://hdl.handle.net/11323/10942
dc.identifier.doi.none.fl_str_mv	10.3390/ijerph19084604
dc.identifier.instname.spa.fl_str_mv	Corporación Universidad de la Costa
dc.identifier.reponame.spa.fl_str_mv	REDICUC - Repositorio CUC
dc.identifier.repourl.spa.fl_str_mv	https://repositorio.cuc.edu.co
identifier_str_mv	Clemente-Suárez, V.J.; Redondo-Flórez, L.; Rubio-Zarapuz, A.; Martínez-Guardado, I.; Navarro-Jiménez, E.; TorneroAguilera, J.F. Nutritional and Exercise Interventions in Cancer-Related Cachexia: An Extensive Narrative Review. Int. J. Environ. Res. Public Health 2022, 19, 4604. https://doi.org/10.3390/ijerph19084604 1661-7827 10.3390/ijerph19084604 Corporación Universidad de la Costa REDICUC - Repositorio CUC
url	https://hdl.handle.net/11323/10942 https://repositorio.cuc.edu.co
dc.language.iso.spa.fl_str_mv	eng
language	eng
dc.relation.ispartofjournal.spa.fl_str_mv	International Journal of Environmental Research and Public Health
dc.relation.references.spa.fl_str_mv	1. Marshall, K.M.; Loeliger, J.; Nolte, L.; Kelaart, A.; Kiss, N.K. Prevalence of malnutrition and impact on clinical outcomes in cancer services: A comparison of two time points. Clin. Nutr. 2019, 38, 644–651. [CrossRef] 2. Cederholm, T.; Barazzoni, R.; Austin, P.; Ballmer, P.; Biolo, G.; Bischoff, S.C.; Compher, C.; Correia, I.; Higashiguchi, T.; Holst, M.; et al. ESPEN guidelines on definitions and terminology of clinical nutrition. Clin. Nutr. 2017, 36, 49–64. [CrossRef] [PubMed] 3. Bower, J.E.; Ganz, P.A.; Tao, M.L.; Hu, W.; Belin, T.R.; Sepah, S.; Cole, S.; Aziz, N. Inflammatory biomarkers and fatigue during radiation therapy for breast and prostate cancer. Clin. Cancer Res. 2009, 15, 5534–5540. [CrossRef] [PubMed] 4. Bower, J.E.; Lamkin, D.M. Inflammation and cancer-related fatigue: Mechanisms, contributing factors, and treatment implications. Brain. Behav. Immun. 2013, 30, S48–S57. [CrossRef] 5. Morishita, S. Prevalence of sarcopenia in cancer patients: Review and future directions. Int. J. Phys. Med. Rehabil. 2016, 4, 342. [CrossRef] 6. Zhang, X.; Tang, T.; Pang, L.; Sharma, S.V.; Li, R.; Nyitray, A.G.; Edwards, B.J. Malnutrition and overall survival in older adults with cancer: A systematic review and meta-analysis. J. Geriatr. Oncol. 2019, 10, 874–883. [CrossRef] 7. Wang, S.-L.; Zhuang, C.-L.; Huang, D.-D.; Pang, W.-Y.; Lou, N.; Chen, F.-F.; Zhou, C.-J.; Shen, X.; Yu, Z. Sarcopenia adversely impacts postoperative clinical outcomes following gastrectomy in patients with gastric cancer: A prospective study. Ann. Surg. Oncol. 2016, 23, 556–564. [CrossRef] 8. Curtis, A.R.; Livingstone, K.M.; Daly, R.M.; Marchese, L.E.; Kiss, N. Associations between dietary patterns and malnutrition, low muscle mass and sarcopenia in adults with cancer: A scoping review. Int. J. Environ. Res. Public Health 2022, 19, 1769. [CrossRef] 9. Nipp, R.D.; Fuchs, G.; El-Jawahri, A.; Mario, J.; Troschel, F.M.; Greer, J.A.; Gallagher, E.R.; Jackson, V.A.; Kambadakone, A.; Hong, T.S.; et al. Sarcopenia is associated with quality of life and depression in patients with advanced cancer. Oncologist 2018, 23, 97–104. [CrossRef] 10. Baguley, B.J.; Bolam, K.A.; Wright, O.R.L.; Skinner, T.L. The effect of nutrition therapy and exercise on cancer-related fatigue and quality of life in men with prostate cancer: A systematic review. Nutrients 2017, 9, 1003. [CrossRef] 11. Minnella, E.M.; Awasthi, R.; Loiselle, S.E.; Agnihotram, R.V.; Ferri, L.E.; Carli, F. Effect of exercise and nutrition prehabilitation on functional vapacity in esophagogastric cancer surgery: A randomized clinical trial. JAMA Surg. 2018, 153, 1081–1089. [CrossRef] [PubMed] 12. Sadeghi, F.; Mockler, D.; Guinan, E.M.; Hussey, J.; Doyle, S.L. The effectiveness of nutrition interventions combined with exercise in upper gastrointestinal cancers: A systematic review. Nutrients 2021, 13, 2842. [CrossRef] [PubMed] 13. Burden, S.; Jones, D.J.; Sremanakova, J.; Sowerbutts, A.M.; Lal, S.; Pilling, M.; Todd, C. Dietary interventions for adult cancer survivors. Cochrane Database Syst. Rev. 2019, 2019, CD011287. [CrossRef] [PubMed] 14. Mefferd, K.; Nichols, J.F.; Pakiz, B.; Rock, C.L. A cognitive behavioral therapy intervention to promote weight loss improves body composition and blood lipid profiles among overweight breast cancer survivors. Breast Cancer Res. Treat. 2007, 104, 145–152. [CrossRef] [PubMed] 15. Swisher, A.K.; Abraham, J.; Bonner, D.; Gilleland, D.; Hobbs, G.; Kurian, S.; Yanosik, M.A.; Vona-Davis, L. Exercise and dietary advice intervention for survivors of triple-negative breast cancer: Effects on body fat, physical function, quality of life, and adipokine profile. Support. Care Cancer 2015, 23, 2995–3003. [CrossRef] 16. Demark-Wahnefried, W.; Rogers, L.Q.; Gibson, J.T.; Harada, S.; Frugé, A.D.; Oster, R.A.; Grizzle, W.E.; Norian, L.A.; Yang, E.S.; Della Manna, D.; et al. Randomized trial of weight loss in primary breast cancer: Impact on body composition, circulating biomarkers and tumor characteristics. Int. J. Cancer 2020, 146, 2784–2796. [CrossRef] 17. O’Neill, L.M.; Guinan, E.; Doyle, S.L.; Bennett, A.E.; Murphy, C.; Elliott, J.A.; O’Sullivan, J.; Reynolds, J.V.; Hussey, J. The RESTORE randomized controlled trial: Impact of a multidisciplinary rehabilitative program on cardiorespiratory fitness in esophagogastric cancer survivorship. Ann. Surg. 2018, 268, 747–755. [CrossRef] 18. Scott, E.; Daley, A.J.; Doll, H.; Woodroofe, N.; Coleman, R.E.; Mutrie, N.; Crank, H.; Powers, H.J.; Saxton, J.M. Effects of an exercise and hypocaloric healthy eating program on biomarkers associated with long-term prognosis after early-stage breast cancer: A randomized controlled trial. Cancer Causes Control 2013, 24, 181–191. [CrossRef] 19. Fiuza-Luces, C.; Garatachea, N.; Berger, N.A.; Lucia, A. Exercise is the real polypill. Physiology 2013, 28, 330–358. [CrossRef] 20. Buffart, L.M.; Galvão, D.A.; Brug, J.; Chinapaw, M.J.M.; Newton, R.U. Evidence-based physical activity guidelines for cancer survivors: Current guidelines, knowledge gaps and future research directions. Cancer Treat. Rev. 2014, 40, 327–340. [CrossRef] 21. Clemente-Suárez, V.J.; Beltrán-Velasco, A.I.; Ramos-Campo, D.J.; Mielgo-Ayuso, J.; Nikolaidis, P.A.; Belando, N.; Tornero-Aguilera, J.F. Physical activity and COVID-19. The basis for an efficient intervention in times of COVID-19 pandemic. Physiol. Behav. 2022, 244, 113667. [CrossRef] [PubMed] 22. Clemente-Suárez, V.J.; Ramos-Campo, D.J.; Mielgo-Ayuso, J.; Dalamitros, A.A.; Nikolaidis, P.A.; Hormeño-Holgado, A.; Tornero-Aguilera, J.F. Nutrition in the actual Covid-19 pandemic. A narrative review. Nutrients 2021, 13, 1924. [CrossRef] [PubMed] 23. Clemente-Suárez, V.J.; Navarro-Jiménez, E.; Ruisoto, P.; Dalamitros, A.A.; Beltran-Velasco, A.I.; Hormeño-Holgado, A.; Laborde-Cárdenas, C.C.; Tornero-Aguilera, J.F. Performance of fuzzy multi-criteria decision analysis of emergency system in Covid-19 pandemic. An extensive narrative review. Int. J. Environ. Res. Public Health 2021, 18, 5208. [CrossRef] [PubMed] 24. World Health Organization WHO Report on Cancer: Setting Priorities, Investing Wisely and Providing Care for All. Available online: https://www.who.int/publications/i/item/who-report-on-cancer-setting-priorities-investing-wisely-and-providingcare-for-all (accessed on 14 February 2022). 25. Muscaritoli, M.; Lucia, S.; Farcomeni, A.; Lorusso, V.; Saracino, V.; Barone, C.; Plastino, F.; Gori, S.; Magarotto, R.; Carteni, G.; et al. Prevalence of malnutrition in patients at first medical oncology visit: The PreMiO study. Oncotarget 2017, 8, 79884–79896. [CrossRef] 26. Luengo-Fernandez, R.; Leal, J.; Gray, A.; Sullivan, R. Economic burden of cancer across the European Union: A population-based cost analysis. Lancet Oncol. 2013, 14, 1165–1174. [CrossRef] 27. Shpata, V.; Prendushi, X.; Kreka, M.; Kola, I.; Kurti, F.; Ohri, I. Malnutrition at the time of surgery affects negatively the clinical outcome of critically ill patients with gastrointestinal cancer. Med. Arch. 2014, 68, 263–267. [CrossRef] 28. Chang, C.H.; Qiu, J.; O’Sullivan, D.; Buck, M.D.; Noguchi, T.; Curtis, J.D.; Chen, Q.; Gindin, M.; Gubin, M.M.; van der Windt, G.J.W.; et al. Metabolic competition in the tumor microenvironment is a driver of cancer progression. Cell 2015, 162, 1229–1241. [CrossRef] 29. Baracos, V.E. Cancer-associated malnutrition. Eur. J. Clin. Nutr. 2018, 72, 1255–1259. [CrossRef] 30. Van Cutsem, E.; Arends, J. The causes and consequences of cancer-associated malnutrition. Eur. J. Oncol. Nurs. 2005, 9 (Suppl. 2), S51–S63. [CrossRef] 31. Mialich, M.S.; Sicchieri, J.M.F.; Junior, A.A.J. Analysis of body composition: A critical review of the use of bioelectrical impedance analysis. Int. J. Clin. Nutr. 2014, 2, 1–10. 32. Argilés, J.M. Cancer-associated malnutrition. Eur. J. Oncol. Nurs. 2005, 9 (Suppl. 2), S39–S50. [CrossRef] [PubMed] 33. Nordhausen, K.; Solass, W.; Demtroeder, C.; Tempfer, C.B.; Reymond, M. Cachexia-anorexia syndrome in patients with peritoneal metastasis: An observational study. Pleura Peritoneum 2016, 1, 57–63. [CrossRef] [PubMed] 34. Mantovani, G.; Madeddu, C. Cancer cachexia: Medical management. Support. Care Cancer 2010, 18, 1–9. [CrossRef] [PubMed] 35. Vander Heiden, M.G.; Cantley, L.C.; Thompson, C.B. Understanding the Warburg Effect: The metabolic requirements of cell proliferation. Science 2009, 324, 1029–1033. [CrossRef] 36. Argilés, J.M.; Campos, N.; Lopez-Pedrosa, J.M.; Rueda, R.; Rodriguez-Mañas, L. Skeletal Muscle regulates metabolism via interorgan crosstalk: Roles in health and disease. J. Am. Med. Dir. Assoc. 2016, 17, 789–796. [CrossRef] 37. Da Fonseca, G.W.P.; Farkas, J.; Dora, E.; von Haehling, S.; Lainscak, M. Cancer cachexia and related metabolic dysfunction. Int. J. Mol. Sci. 2020, 21, 2321. [CrossRef] 38. Ebadi, M.; Mazurak, V.C. Evidence and mechanisms of fat depletion in cancer. Nutrients 2014, 6, 5280–5297. [CrossRef] 39. Agustsson, T.; Rydén, M.; Hoffstedt, J.; van Harmelen, V.; Dicker, A.; Laurencikiene, J.; Isaksson, B.; Permert, J.; Arner, P. Mechanism of increased lipolysis in cancer cachexia. Cancer Res. 2007, 67, 5531–5537. [CrossRef] 40. Mracek, T.; Stephens, N.A.; Gao, D.; Bao, Y.; Ross, J.A.; Rydén, M.; Arner, P.; Trayhurn, P.; Fearon, K.C.H.; Bing, C. Enhanced ZAG production by subcutaneous adipose tissue is linked to weight loss in gastrointestinal cancer patients. Br. J. Cancer 2011, 104, 441–447. [CrossRef] 41. Russell, S.T.; Hirai, K.; Tisdale, M.J. Role of β3-adrenergic receptors in the action of a tumour lipid mobilizing factor. Br. J. Cancer 2002, 86, 424–428. [CrossRef] 42. Cero, C.; Lea, H.J.; Zhu, K.Y.; Shamsi, F.; Tseng, Y.H.; Cypess, A.M. β3 -Adrenergic receptors regulate human brown/beige adipocyte lipolysis and thermogenesis. JCI Insight 2021, 6. [CrossRef] 43. Elattar, S.; Dimri, M.; Satyanarayana, A. The tumor secretory factor ZAG promotes white adipose tissue browning and energy wasting. FASEB J. 2018, 32, 4727–4743. [CrossRef] [PubMed] 44. Dev, R.; Bruera, E.; Dalal, S. Insulin resistance and body composition in cancer patients. Ann. Oncol. 2018, 29 (Suppl. 2), ii18–ii26. [CrossRef] 45. Fearon, K.C.H.; Glass, D.J.; Guttridge, D.C. Cancer cachexia: Mediators, signaling, and metabolic pathways. Cell Metab. 2012, 16, 153–166. [CrossRef] 46. Han, J.; Meng, Q.; Shen, L.; Wu, G. Interleukin-6 induces fat loss in cancer cachexia by promoting white adipose tissue lipolysis and browning. Lipids Health Dis. 2018, 17, 14. [CrossRef] [PubMed] 47. Vegiopoulos, A.; Rohm, M.; Herzig, S. Adipose tissue: Between the extremes. EMBO J. 2017, 36, 1999–2017. [CrossRef] [PubMed] 48. Rofe, A.M.; Bourgeois, C.S.; Coyle, P.; Taylor, A.; Abdi, E.A. Altered insulin response to glucose in weight-losing cancer patients. Anticancer Res. 1994, 14, 647–650. 49. Burns, J.S.; Manda, G. Metabolic pathways of thewarburg effect in health and disease: Perspectives of choice, chain or chance. Int. J. Mol. Sci. 2017, 18, 2755. [CrossRef] 50. MacAdams, J.; Winter, A.; Morais, J.A.; Burgess, S.C.; Chevalier, S. Elevated gluconeogenesis in aging and lung cancer is related to inflammation and blunted insulin-induced protein anabolism. FASEB J. 2013, 27, 1074.10. [CrossRef] 51. Armstrong, V.S.; Fitzgerald, L.W.; Bathe, O.F. Cancer-associated muscle wasting—candidate mechanisms and molecular pathways. Int. J. Mol. Sci. 2020, 21, 9268. [CrossRef] 52. Koyama, S.; Hata, S.; Witt, C.C.; Ono, Y.; Lerche, S.; Ojima, K.; Chiba, T.; Doi, N.; Kitamura, F.; Tanaka, K.; et al. Muscle RING-Finger Protein-1 (MuRF1) as a connector of muscle energy metabolism and protein synthesis. J. Mol. Biol. 2008, 376, 1224–1236. [CrossRef] [PubMed] 53. Witt, S.H.; Granzier, H.; Witt, C.C.; Labeit, S. MURF-1 and MURF-2 target a specific subset of myofibrillar proteins redundantly: Towards understanding MURF-dependent muscle ubiquitination. J. Mol. Biol. 2005, 350, 713–722. [CrossRef] [PubMed] 54. Fielitz, J.; Kim, M.S.; Shelton, J.M.; Latif, S.; Spencer, J.A.; Glass, D.J.; Richardson, J.A.; Bassel-Duby, R.; Olson, E.N. Myosin accumulation and striated muscle myopathy result from the loss of muscle RING finger 1 and 3. J. Clin. Investig. 2007, 117, 2486–2495. [CrossRef] [PubMed] 55. Bodine, S.C.; Baehr, L.M. Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx/atrogin-1. Am. J. Physiol. Endocrinol. Metab. 2014, 307, E469–E484. [CrossRef] [PubMed] 56. Adams, V.; Mangner, N.; Gasch, A.; Krohne, C.; Gielen, S.; Hirner, S.; Thierse, H.J.; Witt, C.C.; Linke, A.; Schuler, G.; et al. Induction of MuRF1 is essential for TNF-α-induced loss of muscle function in mice. J. Mol. Biol. 2008, 384, 48–59. [CrossRef] 57. Li, H.; Malhotra, S.; Kumar, A. Nuclear factor-kappa B signaling in skeletal muscle atrophy. J. Mol. Med. 2008, 86, 1113–1126. [CrossRef] 58. Zhao, J.; Brault, J.J.; Schild, A.; Cao, P.; Sandri, M.; Schiaffino, S.; Lecker, S.H.; Goldberg, A.L. FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells. Cell Metab. 2007, 6, 472–483. [CrossRef] 59. Dogra, C.; Changoua, H.; Wedhas, N.; Qin, X.; Wergedal, J.E.; Kumar, A. TNF-related weak inducer of apoptosis (TWEAK) is a potent skeletal muscle-wasting cytokine. FASEB J. 2007, 21, 1857–1869. [CrossRef] 60. Stitt, T.N.; Drujan, D.; Clarke, B.A.; Panaro, F.; Timofeyva, Y.; Kline, W.O.; Gonzalez, M.; Yancopoulos, G.D.; Glass, D.J. The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol. Cell 2004, 14, 395–403. [CrossRef] 61. García-Prat, L.; Perdiguero, E.; Alonso-Martín, S.; Dell’Orso, S.; Ravichandran, S.; Brooks, S.R.; Juan, A.H.; Campanario, S.; Jiang, K.; Hong, X.; et al. FoxO maintains a genuine muscle stem-cell quiescent state until geriatric age. Nat. Cell Biol. 2020, 22, 1307–1318. [CrossRef] 62. Huang, X.Y.; Huang, Z.L.; Yang, J.H.; Xu, Y.H.; Sun, J.S.; Zheng, Q.; Wei, C.; Song, W.; Yuan, Z. Pancreatic cancer cell-derived IGFBP-3 contributes to muscle wasting. J. Exp. Clin. Cancer Res. 2016, 35, 46. [CrossRef] [PubMed] 63. Salih, D.A.M.; Tripathi, G.; Holding, C.; Szestak, T.A.M.; Gonzalez, M.I.; Carter, E.J.; Cobb, L.J.; Eisemann, J.E.; Pell, J.M. Insulinlike growth factor-binding protein 5 (Igfbp5) compromises survival, growth, muscle development, and fertility in mice. Proc. Natl. Acad. Sci. USA 2004, 101, 4314–4319. [CrossRef] [PubMed] 64. Wang, F.; Liu, H.; Hu, L.; Liu, Y.; Duan, Y.; Cui, R.; Tian, W. The Warburg Effect in human pancreatic cancer cells triggers cachexia in athymic mice carrying the cancer cells. BMC Cancer 2018, 18, 360. [CrossRef] [PubMed] 65. John, A.P. Dysfunctional mitochondria, not oxygen insufficiency, cause cancer cells to produce inordinate amounts of lactic acid: The impact of this on the treatment of cancer. Med. Hypotheses 2001, 57, 429–431. [CrossRef] 66. Hainerová, I.A.; Lebl, J. Mechanisms of appetite regulation. J. Pediatr. Gastroenterol. Nutr. 2010, 51 (Suppl. 3), S123–S124. [CrossRef] 67. Ruiz Garcia, V.; López-Briz, E.; Carbonell Sanchis, R.; Gonzalvez Perales, J.L.; Bort-Marti, S. Megestrol acetate for treatment of anorexia-cachexia syndrome. Cochrane Database Syst. Rev. 2013, 2013, CD004310. [CrossRef] 68. Jatoi, A.; Windschitl, H.E.; Loprinzi, C.L.; Sloan, J.A.; Dakhil, S.R.; Mailliard, J.A.; Pundaleeka, S.; Kardinal, C.G.; Fitch, T.R.; Krook, J.E.; et al. Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: A north central cancer treatment group study. J. Clin. Oncol. 2002, 20, 567–573. [CrossRef] 69. Fatima, K.; Andleeb, A.; Hussain, I.; Sofi, M.A.; Fir, A.; Qadri, S.K. Megestrol acetate in cancer cachexia and anorexia: Tertiary care experience. J. Radiat. Cancer Res. 2021, 12, 168–171. [CrossRef] 70. Brisbois, T.D.; de Kock, I.H.; Watanabe, S.M.; Mirhosseini, M.; Lamoureux, D.C.; Chasen, M.; MacDonald, N.; Baracos, V.E.; Wismer, W. V Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: Results of a randomized, double-blind, placebo-controlled pilot trial. Ann. Oncol. 2011, 22, 2086–2093. [CrossRef] 71. Johnson, J.R.; Burnell-Nugent, M.; Lossignol, D.; Ganae-Motan, E.D.; Potts, R.; Fallon, M.T. Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain. J. Pain Symptom Manag. 2010, 39, 167–179. [CrossRef] 72. Yavuzsen, T.; Davis, M.P.; Walsh, D.; LeGrand, S.; Lagman, R. Systematic review of the treatment of cancer-associated anorexia and weight loss. J. Clin. Oncol. 2005, 23, 8500–8511. [CrossRef] [PubMed] 73. Liu, D.; Ahmet, A.; Ward, L.; Krishnamoorthy, P.; Mandelcorn, E.D.; Leigh, R.; Brown, J.P.; Cohen, A.; Kim, H. A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy. Allergy Asthma Clin. Immunol. 2013, 9, 30. [CrossRef] [PubMed] 74. Gasco, V.; Beccuti, G.; Marotta, F.; Benso, A.; Granata, R.; Broglio, F.; Ghigo, E. Endocrine and metabolic actions of ghrelin. In Pediatric Neuroendocrinology; Loche, S., Cappa, M., Ghizzoni, L., Maghnie, M., Savage, M.O., Eds.; Endocrine Development; Karger: Basel, Switzerland, 2010; Volume 17, pp. 86–95. [CrossRef] 75. Lim, C.T.; Kola, B.; Korbonits, M.; Grossman, A.B. Ghrelin’s role as a major regulator of appetite and its other functions in neuroendocrinology. Prog. Brain Res. 2010, 182, 189–205. [CrossRef] 76. Chen, J.A.; Splenser, A.; Guillory, B.; Luo, J.; Mendiratta, M.; Belinova, B.; Halder, T.; Zhang, G.; Li, Y.P.; Garcia, J.M. Ghrelin prevents tumour- and cisplatin-induced muscle wasting: Characterization of multiple mechanisms involved. J. Cachexia Sarcopenia Muscle 2015, 6, 132–143. [CrossRef] [PubMed] 77. Temel, J.S.; Abernethy, A.P.; Currow, D.C.; Friend, J.; Duus, E.M.; Yan, Y.; Fearon, K.C. Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): Results from two randomised, double-blind, phase 3 trials. Lancet Oncol. 2016, 17, 519–531. [CrossRef] 78. Malik, J.S.; Yennurajalingam, S. Prokinetics and ghrelin for the management of cancer cachexia syndrome. Ann. Palliat. Med. 2019, 8, 80–85. [CrossRef] 79. Suzuki, H.; Asakawa, A.; Amitani, H.; Nakamura, N.; Inui, A. Cancer cachexia—Pathophysiology and management. J. Gastroenterol. 2013, 48, 574–594. [CrossRef] 80. Singh, N.; Baby, D.; Rajguru, J.P.; Patil, P.B.; Thakkannavar, S.S.; Pujari, V.B. Inflammation and cancer. Ann. Afr. Med. 2019, 18, 121–126. [CrossRef] 81. Al-Zhoughbi, W.; Huang, J.; Paramasivan, G.S.; Till, H.; Pichler, M.; Guertl-Lackner, B.; Hoefler, G. Tumor macroenvironment and metabolism. Semin. Oncol. 2014, 41, 281–295. [CrossRef] 82. Ni, J.; Zhang, L. Cancer cachexia: Definition, staging, and emerging treatments. Cancer Manag. Res. 2020, 12, 5597–5605. [CrossRef] 83. Schuster, M.; Rigas, J.R.; Orlov, S.V.; Milovanovic, B.; Prabhash, K.; Smith, J.T. ALD518, a humanized anti-IL-6 antibody, treats anemia in patients with advanced non-small cell lung cancer (NSCLC): Results of a phase II, randomized, double-blind, placebo-controlled trial. J. Clin. Oncol. 2010, 28, 7631. [CrossRef] 84. Chauhan, A.; Sequeria, A.; Manderson, C.; Maddocks, M.; Wasley, D.; Wilcock, A. Exploring autonomic nervous system dysfunction in patients with cancer cachexia: A pilot study. Auton. Neurosci. Basic Clin. 2012, 166, 93–95. [CrossRef] [PubMed] 85. Trobec, K.; Palus, S.; Tschirner, A.; von Haehling, S.; Doehner, W.; Lainscak, M.; Anker, S.D.; Springer, J. Rosiglitazone reduces body wasting and improves survival in a rat model of cancer cachexia. Nutrition 2014, 30, 1069–1075. [CrossRef] [PubMed] 86. Auger, C.; Knuth, C.M.; Abdullahi, A.; Samadi, O.; Parousis, A.; Jeschke, M.G. Metformin prevents the pathological browning of subcutaneous white adipose tissue. Mol. Metab. 2019, 29, 12–23. [CrossRef] [PubMed] 87. Oliveira, A.G.; Gomes-Marcondes, M.C.C. Metformin treatment modulates the tumour-induced wasting effects in muscle protein metabolism minimising the cachexia in tumour-bearing rats. BMC Cancer 2016, 16, 418. [CrossRef] 88. Lainscak, M.; Laviano, A. ACT-ONE - ACTION at last on cancer cachexia by adapting a novel action beta-blocker. J. Cachexia Sarcopenia Muscle 2016, 7, 400–402. [CrossRef] 89. von Haehling, S.; Lainscak, M.; Springer, J.; Anker, S.D. Cardiac cachexia: A systematic overview. Pharmacol. Ther. 2009, 121, 227–252. [CrossRef] 90. Pötsch, M.S.; Tschirner, A.; Palus, S.; von Haehling, S.; Doehner, W.; Beadle, J.; Coats, A.J.S.; Anker, S.D.; Springer, J. The anabolic catabolic transforming agent (ACTA) espindolol increases muscle mass and decreases fat mass in old rats. J. Cachexia Sarcopenia Muscle 2014, 5, 149–158. [CrossRef] 91. Stewart Coats, A.J.; Ho, G.F.; Prabhash, K.; von Haehling, S.; Tilson, J.; Brown, R.; Beadle, J.; Anker, S.D. Espindolol for the treatment and prevention of cachexia in patients with stage III/IV non-small cell lung cancer or colorectal cancer: A randomized, double-blind, placebo-controlled, international multicentre phase II study (the ACT-ONE trial). J. Cachexia Sarcopenia Muscle 2016, 7, 355–365. [CrossRef] 92. Pleadin, J.; Vuli´c, A.; Perši, N. β-adrenergic agonists: Substances with anabolic effect in animals for meat production. MESO 2012, 14, 80–87. 93. World Health Organization Nutrition. Available online: https://www.who.int/health-topics/nutrition (accessed on 14 February 2022). 94. Ravasco, P. Nutrition in cancer patients. J. Clin. Med. 2019, 8, 1211. [CrossRef] [PubMed] 95. Donaldson, M.S. Nutrition and cancer: A review of the evidence for an anti-cancer diet. Nutr. J. 2004, 3, 19. [CrossRef] [PubMed] 96. Preiser, J.C.; Schneider, S.M. ESPEN disease-specific guideline framework. Clin. Nutr. 2011, 30, 549–552. [CrossRef] 97. Martin, L.; Senesse, P.; Gioulbasanis, I.; Antoun, S.; Bozzetti, F.; Deans, C.; Strasser, F.; Thoresen, L.; Jagoe, R.T.; Chasen, M.; et al. Diagnostic criteria for the classification of cancer-associated weight loss. J. Clin. Oncol. 2015, 33, 90–99. [CrossRef] [PubMed] 98. Bozzetti, F.; Arends, J.; Lundholm, K.; Micklewright, A.; Zurcher, G.; Muscaritoli, M. ESPEN guidelines on parenteral nutrition: Non-surgical oncology. Clin. Nutr. 2009, 28, 445–454. [CrossRef] [PubMed] 99. Rossi-Fanelli, F.; Franchi, F.; Mulieri, M.; Cangiano, C.; Cascino, A.; Ceci, F.; Muscaritoli, M.; Seminara, P.; Bonomo, L. Effect of energy substrate manipulation on tumour cell proliferation in parenterally fed cancer patients. Clin. Nutr. 1991, 10, 228–232. [CrossRef] 100. Bossola, M.; Pacelli, F.; Rosa, F.; Tortorelli, A.; Battista Doglietto, G. Does nutrition support stimulate tumor growth in humans? Nutr. Clin. Pract. 2011, 26, 174–180. [CrossRef] 101. Warner, E.L.; Waters, A.R.; Cloyes, K.G.; Ellington, L.; Kirchhoff, A.C. Young adult cancer caregivers’ exposure to cancer misinformation on social media. Cancer 2021, 127, 1318–1324. [CrossRef] 102. Arends, J.; Bachmann, P.; Baracos, V.; Barthelemy, N.; Bertz, H.; Bozzetti, F.; Fearon, K.; Hütterer, E.; Isenring, E.; Kaasa, S.; et al. ESPEN guidelines on nutrition in cancer patients. Clin. Nutr. 2017, 36, 11–48. [CrossRef] 103. Baracos, V.E. Skeletal muscle anabolism in patients with advanced cancer. Lancet Oncol. 2014, 16, 13–14. [CrossRef] 104. Nitenberg, G.; Raynard, B. Nutritional support of the cancer patient: Issues and dilemmas. Crit. Rev. Oncol. Hematol. 2000, 34, 137–168. [CrossRef] 105. Barrera, R. Nutritional support in cancer patients. J. Parenter. Enter. Nutr. 2002, 26, S63–S71. [CrossRef] [PubMed] 106. Baracos, V.E. Meeting the amino acid requirements for protein anabolism in cancer cachexia. In Cachexia and Wasting: A Modern Approach; Mantovani, G., Anker, S.D., Inui, A., Morley, J.E., Fanelli, F.R., Scevola, D., Schuster, M.W., Yeh, S.-S., Eds.; Springer: Milan, Italy, 2006; pp. 631–634. 107. Bozzetti, F.; Bozzetti, V. Is the intravenous supplementation of amino acid to cancer patients adequate? A critical appraisal of literature. Clin. Nutr. 2013, 32, 142–146. [CrossRef] [PubMed] 108. Haran, P.H.; Rivas, D.A.; Fielding, R.A. Role and potential mechanisms of anabolic resistance in sarcopenia. J. Cachexia Sarcopenia Muscle 2012, 3, 157–162. [CrossRef] 109. Winter, A.; MacAdams, J.; Chevalier, S. Normal protein anabolic response to hyperaminoacidemia in insulin-resistant patients with lung cancer cachexia. Clin. Nutr. 2012, 31, 765–773. [CrossRef] 110. Cano, N.; Fiaccadori, E.; Tesinsky, P.; Toigo, G.; Druml, W.; Kuhlmann, M.; Mann, H.; Hörl, W.H. ESPEN guidelines on enteral nutrition: Adult renal failure. Clin. Nutr. 2006, 25, 295–310. [CrossRef] 111. Arcidiacono, B.; Iiritano, S.; Nocera, A.; Possidente, K.; Nevolo, M.T.; Ventura, V.; Foti, D.; Chiefari, E.; Brunetti, A. Insulin resistance and cancer risk: An overview of the pathogenetic mechanisms. Exp. Diabetes Res. 2012, 2012, 789174. [CrossRef] [PubMed] 112. Cai, H.; Sobue, T.; Kitamura, T.; Ishihara, J.; Nanri, A.; Mizoue, T.; Iwasaki, M.; Yamaji, T.; Inoue, M.; Tsugane, S.; et al. Lowcarbohydrate diet and risk of cancer incidence: The Japan Public Health Center-based prospective study. Cancer Sci. 2022, 113, 744–755. [CrossRef] [PubMed] 113. Breitkreutz, R.; Tesdal, K.; Jentschura, D.; Haas, O.; Leweling, H.; Holm, E. Effects of a high-fat diet on body composition in cancer patients receiving chemotherapy: A randomized controlled study. Wiener klinische Wochenschrift 2005, 117, 685–692. [CrossRef] 114. Mamede, A.C.; Tavares, S.D.; Abrantes, A.M.; Trindade, J.; Maia, J.M.; Botelho, M.F. The role of vitamins in cancer: A review. Nutr. Cancer 2011, 63, 479–494. [CrossRef] 115. Giovannucci, E.; Chan, A.T. Role of vitamin and mineral supplementation and aspirin use in cancer survivors. J. Clin. Oncol. 2010, 28, 4081–4085. [CrossRef] [PubMed] 116. Food and Agricultural Organization Nutrition. Available online: https://www.fao.org/nutrition/requirements/es/ (accessed on 14 February 2022). 117. Biesalski, H.-K. Mikronährstoffsupplemente bei onkologischen patienten. Der Onkologe 2008, 14, 45–57. [CrossRef] 118. Zürcher, G.; Gola, U.; Biesalski, H.K. Antioxidanzien bei krebs. Schweizer Zeitschrift für Ernährungsmedizin 2007, 4, 17e9. 119. Norman, H.A.; Butrum, R.R.; Feldman, E.; Heber, D.; Nixon, D.; Picciano, M.F.; Rivlin, R.; Simopoulos, A.; Wargovich, M.J.; Weisburger, E.K.; et al. The role of dietary supplements during cancer therapy. J. Nutr. 2003, 133, 3794S–3799S. [CrossRef] 120. Huebner, J.; Marienfeld, S.; Abbenhardt, C.; Ulrich, C.; Muenstedt, K.; Micke, O.; Muecke, R.; Loeser, C. Counseling patients on cancer diets: A review of the literature and recommendations for clinical practice. Anticancer Res. 2014, 34, 39–48. 121. Allen, B.G.; Bhatia, S.K.; Buatti, J.M.; Brandt, K.E.; Lindholm, K.E.; Button, A.M.; Szweda, L.I.; Smith, B.J.; Spitz, D.R.; Fath, M.A. Ketogenic diets enhance oxidative stress and radio-chemo-therapy responses in lung cancer xenografts. Clin. Cancer Res. 2013, 19, 3905–3913. [CrossRef] 122. Bozzetti, F.; Zupec-Kania, B. Toward a cancer-specific diet. Clin. Nutr. 2016, 35, 1188–1195. [CrossRef] 123. Elstrom, R.L.; Bauer, D.E.; Buzzai, M.; Karnauskas, R.; Harris, M.H.; Plas, D.R.; Zhuang, H.; Cinalli, R.M.; Alavi, A.; Rudin, C.M.; et al. Akt stimulates aerobic glycolysis in cancer cells. Cancer Res. 2004, 64, 3892–3899. [CrossRef] 124. Poff, A.M.; Ari, C.; Seyfried, T.N.; D’Agostino, D.P. The Ketogenic Diet and Hyperbaric Oxygen Therapy Prolong Survival in Mice with Systemic Metastatic Cancer. PLoS ONE 2013, 8, e65522. [CrossRef] 125. Bozzetti, F.; Santarpia, L.; Pironi, L.; Thul, P.; Klek, S.; Gavazzi, C.; Tinivella, M.; Joly, F.; Jonkers, C.; Baxter, J.; et al. The prognosis of incurable cachectic cancer patients on home parenteral nutrition: A multi-centre observational study with prospective follow-up of 414 patients. Ann. Oncol. 2014, 25, 487–493. [CrossRef] 126. Brennan, M.F.; Pisters, P.W.; Posner, M.; Quesada, O.; Shike, M. A prospective randomized trial of total parenteral nutrition after major pancreatic resection for malignancy. Ann. Surg. 1994, 220, 436–444. [CrossRef] [PubMed] 127. Scolapio, J.S.; Ukleja, A.; Burnes, J.U.; Kelly, D.G. Outcome of patients with radiation enteritis treated with home parenteral nutrition. Am. J. Gastroenterol. 2002, 97, 662–666. [CrossRef] [PubMed] 128. Staun, M.; Pironi, L.; Bozzetti, F.; Baxter, J.; Forbes, A.; Joly, F.; Jeppesen, P.; Moreno, J.; Hébuterne, X.; Pertkiewicz, M.; et al. ESPEN guidelines on parenteral nutrition: Home parenteral nutrition (HPN) in adult patients. Clin. Nutr. 2009, 28, 467–479. [CrossRef] [PubMed] 129. Binns, C.W.; Lee, M.K.; Lee, A.H. Problems and prospects: Public health regulation of dietary supplements. Annu. Rev. Public Health 2018, 39, 403–420. [CrossRef] 130. Maughan, R.J.; Burke, L.M.; Dvorak, J.; Larson-Meyer, D.E.; Peeling, P.; Phillips, S.M.; Rawson, E.S.; Walsh, N.P.; Garthe, I.; Geyer, H.; et al. IOC consensus statement: Dietary supplements and the high-performance athlete. Int. J. Sport Nutr. Exerc. Metab. 2018, 28, 104–125. [CrossRef] 131. Kami ´nski, M.; Kr˛egielska-Narozna, M.; Bogda ´nski, P. Determination of the popularity of dietary supplements using google search ˙ rankings. Nutrients 2020, 12, 908. [CrossRef] [PubMed] 132. Aysin, E.; Urhan, M. Dramatic increase in dietary supplement use during Covid-19. Curr. Dev. Nutr. 2021, 5, 207. [CrossRef] 133. Garthe, I.; Maughan, R.J. Athletes and supplements: Prevalence and perspectives. Int. J. Sport Nutr. Exerc. Metab. 2018, 28, 126–138. [CrossRef] 134. Adami, P.E.; Koutlianos, N.; Baggish, A.; Bermon, S.; Cavarretta, E.; Deligiannis, A.; Furlanello, F.; Kouidi, E.; Marques-Vidal, P.; Niebauer, J.; et al. Cardiovascular effects of doping substances, commonly prescribed medications and ergogenic aids in relation to sports: A position statement of the sport cardiology and exercise nucleus of the European Association of Preventive Cardiology. Eur. J. Prev. Cardiol. 2022, 29, 559–575. [CrossRef] 135. Tayek, J.A.; Bistrian, B.R.; Hehir, D.J.; Martin, R.; Moldawer, L.L.; Blackburn, G.L. Improved protein kinetics and albumin synthesis by branched chain amino acid-enriched total parenteral nutrition in cancer cachexia: A prospective randomized crossover trial. Cancer 1986, 58, 147–157. [CrossRef] 136. Hunter, D.C.; Weintraub, M.; Blackburn, G.L.; Bistrian, B.R. Branched chain amino acids as the protein component of parenteral nutrition in cancer cachexia. Br. J. Surg. 1989, 76, 149–153. [CrossRef] [PubMed] 137. Deutz, N.E.P.; Safar, A.; Schutzler, S.; Memelink, R.; Ferrando, A.; Spencer, H.; van Helvoort, A.; Wolfe, R.R. Muscle protein synthesis in cancer patients can be stimulated with a specially formulated medical food. Clin. Nutr. 2011, 30, 759–768. [CrossRef] 138. Tydeman-Edwards, R. Glutamine and its use in selected oncology settings. S. Afr. J. Clin. Nutr. 2017, 30, 109–117. [CrossRef] 139. Cruz-Jentoft, A.J. Beta-hydroxy-beta-methyl butyrate (HMB): From experimental data to clinical evidence in sarcopenia. Curr. Protein Pept. Sci. 2018, 19, 668–672. [CrossRef] [PubMed] 140. Akutsu, Y.; Kono, T.; Uesato, M.; Hoshino, I.; Murakami, K.; Fujishiro, T.; Imanishi, S.; Endo, S.; Toyozumi, T.; Matsubara, H. Are additional trace elements necessary in total parenteral nutrition for patients with esophageal cancer receiving cisplatin-based chemotherapy? Biol. Trace Elem. Res. 2012, 150, 109–115. [CrossRef] 141. Rock, C.L.; Doyle, C.; Demark-Wahnefried, W.; Meyerhardt, J.; Courneya, K.S.; Schwartz, A.L.; Bandera, E.V.; Hamilton, K.K.; Grant, B.; McCullough, M.; et al. Nutrition and physical activity guidelines for cancer survivors. CA Cancer J. Clin. 2012, 62, 242–274. [CrossRef] 142. Horneber, M.; Bueschel, G.; Dennert, G.; Less, D.; Ritter, E.; Zwahlen, M. How many cancer patients use complementary and alternative medicine: A systematic review and metaanalysis. Integr. Cancer Ther. 2012, 11, 187–203. [CrossRef] 143. Bjelakovic, G.; Nikolova, D.; Gluud, L.L.; Simonetti, R.G.; Gluud, C. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: Systematic review and meta-analysis. JAMA 2007, 297, 842–857. [CrossRef] 144. Lawson, K.A.; Wright, M.E.; Subar, A.; Mouw, T.; Hollenbeck, A.; Schatzkin, A.; Leitzmann, M.F. Multivitamin use and risk of prostate cancer in the national institutes of health—AARP diet and health study. J. Natl. Cancer Inst. 2007, 99, 754–764. [CrossRef] 145. Higgins, M.R.; Izadi, A.; Kaviani, M. Antioxidants and exercise performance: With a focus on vitamin E and C supplementation. Int. J. Environ. Res. Public Health 2020, 17, 8452. [CrossRef] 146. Ristow, M.; Zarse, K.; Oberbach, A.; Klöting, N.; Birringer, M.; Kiehntopf, M.; Stumvoll, M.; Kahn, C.R.; Blüher, M. Antioxidants prevent health-promoting effects of physical exercise in humans. Proc. Natl. Acad. Sci. USA 2009, 106, 8665–8670. [CrossRef] [PubMed] 147. The Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group. The Effect of Vitamin E and Beta Carotene on the Incidence of Lung Cancer and Other Cancers in Male Smokers. N. Engl. J. Med. 1994, 330, 1029–1035. [CrossRef] [PubMed] 148. Klein, E.A.; Thompson, I.M.; Tangen, C.M.; Crowley, J.J.; Lucia, M.S.; Goodman, P.J.; Minasian, L.M.; Ford, L.G.; Parnes, H.L.; Gaziano, J.M.; et al. Vitamin E and the risk of prostate cancer: The Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 2011, 306, 1549–1556. [CrossRef] [PubMed] 149. Kenfield, S.A.; Van Blarigan, E.L.; DuPre, N.; Stampfer, M.J.; Giovannucci, E.L.; Chan, J.M. Selenium supplementation and prostate cancer mortality. J. Natl. Cancer Inst. 2015, 107, dju360. [CrossRef] [PubMed] 150. Wang, L.; Sesso, H.D.; Glynn, R.J.; Christen, W.G.; Bubes, V.; Manson, J.E.; Buring, J.E.; Gaziano, J.M. Vitamin E and C supplementation and risk of cancer in men: Posttrial follow-up in the Physicians’ Health Study II randomized trial. Am. J. Clin. Nutr. 2014, 100, 915–923. [CrossRef] 151. Konopka, A.R.; Harber, M.P. Skeletal muscle hypertrophy after aerobic exercise training. Exerc. Sport Sci. Rev. 2014, 42, 53–61. [CrossRef] 152. Garber, C.E.; Blissmer, B.; Deschenes, M.R.; Franklin, B.A.; Lamonte, M.J.; Lee, I.M.; Nieman, D.C.; Swain, D.P. American college of sports medicine position stand. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: Guidance for prescribing exercise. Med. Sci. Sports Exerc. 2011, 43, 1334–1359. [CrossRef] 153. Grgic, J.; Mcllvenna, L.C.; Fyfe, J.J.; Sabol, F.; Bishop, D.J.; Schoenfeld, B.J.; Pedisic, Z. Does aerobic training promote the same skeletal muscle hypertrophy as resistance training? A systematic review and meta-analysis. Sport. Med. 2019, 49, 233–254. [CrossRef] 154. Konopka, A.R.; Douglass, M.D.; Kaminsky, L.A.; Jemiolo, B.; Trappe, T.A.; Trappe, S.; Harber, M.P. Molecular adaptations to aerobic exercise training in skeletal muscle of older women. J. Gerontol. A. Biol. Sci. Med. Sci. 2010, 65A, 1201–1207. [CrossRef] 155. Konopka, A.R.; Suer, M.K.; Wolff, C.A.; Harber, M.P. Markers of human skeletal muscle mitochondrial biogenesis and quality control: Effects of age and aerobic exercise training. J. Gerontol. A. Biol. Sci. Med. Sci. 2014, 69, 371–378. [CrossRef] 156. Short, K.R.; Vittone, J.L.; Bigelow, M.L.; Proctor, D.N.; Nair, K.S. Age and aerobic exercise training effects on whole body and muscle protein metabolism. Am. J. Physiol. Endocrinol. Metab. 2004, 286, E92–E101. [CrossRef] [PubMed] 157. Morinaga, M.; Sako, N.; Isobe, M.; Lee-Hotta, S.; Sugiura, H.; Kametaka, S. Aerobic exercise ameliorates cancer cachexia-induced muscle wasting through adiponectin signaling. Int. J. Mol. Sci. 2021, 22, 3110. [CrossRef] [PubMed] 158. Hardee, J.P.; Montalvo, R.N.; Carson, J.A. Linking cancer cachexia-induced anabolic resistance to skeletal muscle oxidative metabolism. Oxid. Med. Cell. Longev. 2017, 2017, 8018197. [CrossRef] [PubMed] 159. Pigna, E.; Berardi, E.; Aulino, P.; Rizzuto, E.; Zampieri, S.; Carraro, U.; Kern, H.; Merigliano, S.; Gruppo, M.; Mericskay, M.; et al. Aerobic Exercise and Pharmacological Treatments Counteract Cachexia by Modulating Autophagy in Colon Cancer. Sci. Rep. 2016, 6, 26991. [CrossRef] 160. Ballarò, R.; Penna, F.; Pin, F.; Gómez-Cabrera, M.C.; Viña, J.; Costelli, P. Moderate exercise improves experimental cancer cachexia by modulating the redox homeostasis. Cancers 2019, 11, 285. [CrossRef] 161. Niels, T.; Tomanek, A.; Freitag, N.; Schumann, M. Can Exercise Counteract Cancer Cachexia? A Systematic Literature Review and Meta-Analysis. Integr. Cancer Ther. 2020, 19, 1–14. [CrossRef] 162. Khamoui, A.V.; Park, B.S.; Kim, D.H.; Yeh, M.C.; Oh, S.L.; Elam, M.L.; Jo, E.; Arjmandi, B.H.; Salazar, G.; Grant, S.C.; et al. Aerobic and resistance training dependent skeletal muscle plasticity in the colon-26 murine model of cancer cachexia. Metabolism 2016, 65, 685–698. [CrossRef] 163. Gholamian, S.; Hosseini, S.R.A.; Rashidlamir, A.; Aghaalinejad, H. The effects of interval aerobic training on mesenchymal biomarker gene expression, the rate of tumor volume, and cachexia in mice with breast cancer. Iran. J. Basic Med. Sci. 2020, 23, 244–250. [CrossRef] 164. Molanouri Shamsi, M.; Chekachak, S.; Soudi, S.; Quinn, L.S.; Rangbar, K.; Chenari, J.; Yazdi, M.H.; Mahdavi, M. Combined effect of aerobic interval training and selenium nanoparticles on expression of IL-15 and IL-10/TNF-α ratio in skeletal muscle of 4T1 breast cancer mice with cachexia. Cytokine 2017, 90, 100–108. [CrossRef] 165. Moreira, V.M.; da Silva Franco, C.C.; Prates, K.V.; Gomes, R.M.; de Moraes, A.M.P.; Ribeiro, T.A.; Martins, I.P.; Previate, C.; Pavanello, A.; Matiusso, C.C.I.; et al. Aerobic exercise training attenuates tumor growth and reduces insulin secretion in walker 256 tumor-bearing rats. Front. Physiol. 2018, 9, 465. [CrossRef] 166. Alves, C.R.R.; Neves, W.D.; de Almeida, N.R.; Eichelberger, E.J.; Jannig, P.R.; Voltarelli, V.A.; Tobias, G.C.; Bechara, L.R.G.; de Paula Faria, D.; Alves, M.J.N.; et al. Exercise training reverses cancer-induced oxidative stress and decrease in muscle COPS2/TRIP15/ALIEN. Mol. Metab. 2020, 39, 101012. [CrossRef] [PubMed] 167. Grande, A.J.; Silva, V.; Sawaris Neto, L.; Teixeira Basmage, J.P.; Peccin, M.S.; Maddocks, M. Exercise for cancer cachexia in adults. Cochrane Database Syst. Rev. 2021, 2021, CD010804. [CrossRef] 168. Bordignon, C.; Dos Santos, B.S.; Rosa, D.D. Impact of cancer cachexia on cardiac and skeletal muscle: Role of exercise training. Cancers 2022, 14, 342. [CrossRef] [PubMed] 169. Karlsen, T.; Aamot, I.L.; Haykowsky, M.; Rognmo, Ø. High intensity interval training for maximizing health outcomes. Prog. Cardiovasc. Dis. 2017, 60, 67–77. [CrossRef] 170. Rodriguez, A.L.; Whitehurst, M.; Fico, B.G.; Dodge, K.M.; Ferrandi, P.J.; Pena, G.; Adelman, A.; Huang, C.J. Acute high-intensity interval exercise induces greater levels of serum brain-derived neurotrophic factor in obese individuals. Exp. Biol. Med. 2018, 243, 1153–1160. [CrossRef] [PubMed] 171. Papadopoulos, E.; Santa Mina, D. Can we HIIT cancer if we attack inflammation? Cancer Causes Control 2018, 29, 7–11. [CrossRef] 172. O’Donovan, G.; Lee, I.M.; Hamer, M.; Stamatakis, E. Association of “weekend warrior” and other leisure time physical activity patterns with risks for all-cause, cardiovascular disease, and cancer mortality. JAMA Intern. Med. 2017, 177, 335–342. [CrossRef] 173. Callahan, M.J.; Parr, E.B.; Hawley, J.A.; Camera, D.M. Can High-Intensity Interval Training Promote Skeletal Muscle Anabolism? Sports Med. 2021, 51, 405–421. [CrossRef] 174. Ahmadabadi, F.; Saghebjoo, M.; Huang, C.J.; Saffari, I.; Zardast, M. The effects of high-intensity interval training and saffron aqueous extract supplementation on alterations of body weight and apoptotic indices in skeletal muscle of 4T1 breast cancerbearing mice with cachexia. Appl. Physiol. Nutr. Metab. 2020, 45, 555–563. [CrossRef] 175. Ahmadabadi, F.; Saghebjoo, M.; Hoshyar, R. Decreased Liver Tissue Wasting following High-Intensity Interval Training through Apoptosis Signaling Suppression in Breast Tumor–Bearing Female Mice. Iran. Q. J. Breast Dis. 2020, 13, 49–58. [CrossRef] 176. Alves, C.R.R.; da Cunha, T.F.; da Paixão, N.A.; Brum, P.C. Aerobic exercise training as therapy for cardiac and cancer cachexia. Life Sci. 2015, 125, 9–14. [CrossRef] [PubMed] 177. Niels, T.; Tomanek, A.; Schneider, L.; Hasan, I.; Hallek, M.; Baumann, F.T. Exercise improves patient outcomes in advanced pancreatic cancer patient during medical treatment. Pancreat. Disord. Ther. 2018, 8, 193. [CrossRef] 178. Klika, R.J.; Stafford, L.H. Exercise Oncology: High-Intensity Interval Training for Cancer Survivors. ACSM’s Health Fit. J. 2021, 25, 44–53. [CrossRef] 179. Phillips, S.M.; Winett, R.A. Uncomplicated resistance training and health-related outcomes: Evidence for a public health mandate. Curr. Sports Med. Rep. 2010, 9, 208–213. [CrossRef] [PubMed] 180. Mavropalias, G.; Sim, M.; Taaffe, D.R.; Galvão, D.A.; Spry, N.; Kraemer, W.J.; Häkkinen, K.; Newton, R.U. Exercise medicine for cancer cachexia: Targeted exercise to counteract mechanisms and treatment side effects. J. Cancer Res. Clin. Oncol. 2022. [CrossRef] 181. Goodman, C.A.; Frey, J.W.; Mabrey, D.M.; Jacobs, B.L.; Lincoln, H.C.; You, J.S.; Hornberger, T.A. The role of skeletal muscle mTOR in the regulation of mechanical load-induced growth. J. Physiol. 2011, 589 Pt 22, 5485–5501. [CrossRef] [PubMed] 182. Aquila, G.; Re Cecconi, A.D.; Brault, J.J.; Corli, O.; Piccirillo, R. Nutraceuticals and exercise against muscle wasting during cancer cachexia. Cells 2020, 9, 2536. [CrossRef] 183. Donatto, F.F.; Neves, R.X.; Rosa, F.O.; Camargo, R.G.; Ribeiro, H.; Matos-Neto, E.M.; Seelaender, M. Resistance exercise modulates lipid plasma profile and cytokine content in the adipose tissue of tumour-bearing rats. Cytokine 2013, 61, 426–432. [CrossRef] 184. Capozzi, L.C.; McNeely, M.L.; Lau, H.Y.; Reimer, R.A.; Giese-Davis, J.; Fung, T.S.; Culos-Reed, S.N. Patient-reported outcomes, body composition, and nutrition status in patients with head and neck cancer: Results from an exploratory randomized controlled exercise trial. Cancer 2016, 122, 1185–1200. [CrossRef] 185. Newton, R.U.; Galvão, D.A.; Spry, N.; Joseph, D.; Chambers, S.K.; Gardiner, R.A.; Wall, B.A.; Bolam, K.A.; Taaffe, D.R. Exercise mode specificity for preserving spine and hip bone mineral density in prostate cancer patients. Med. Sci. Sports Exerc. 2019, 51, 607–614. [CrossRef] 186. Wilson, J.M.; Marin, P.J.; Rhea, M.R.; Wilson, S.M.C.; Loenneke, J.P.; Anderson, J.C. Concurrent training: A meta-analysis examining interference of aerobic and resistance exercises. J. Strength Cond. Res. 2012, 26, 2293–2307. [CrossRef] [PubMed] 187. Repka, C.P.; Hayward, R. Oxidative stress and fitness changes in cancer patients after exercise training. Med. Sci. Sports Exerc. 2016, 48, 607–614. [CrossRef] [PubMed] 188. Galvão, D.A.; Taaffe, D.R.; Spry, N.; Joseph, D.; Newton, R.U. Combined resistance and aerobic exercise program reverses muscle loss in men undergoing androgen suppression therapy for prostate cancer without bone metastases: A randomized controlled trial. J. Clin. Oncol. 2010, 28, 340–347. [CrossRef] 189. Schink, K.; Gaßner, H.; Reljic, D.; Herrmann, H.J.; Kemmler, W.; Schwappacher, R.; Meyer, J.; Eskofier, B.M.; Winkler, J.; Neurath, M.F.; et al. Assessment of gait parameters and physical function in patients with advanced cancer participating in a 12-week exercise and nutrition programme: A controlled clinical trial. Eur. J. Cancer Care 2020, 29, e13199. [CrossRef] [PubMed] 190. Lønbro, S.; Dalgas, U.; Primdahl, H.; Johansen, J.; Nielsen, J.L.; Aagaard, P.; Hermann, A.P.; Overgaard, J.; Overgaard, K. Progressive resistance training rebuilds lean body mass in head and neck cancer patients after radiotherapy—Results from the randomized DAHANCA 25B trial. Radiother. Oncol. 2013, 108, 314–319. [CrossRef] 191. Kamel, F.A.H.; Basha, M.A.; Alsharidah, A.S.; Salama, A.B. Resistance training impact on mobility, muscle strength and lean mass in pancreatic cancer cachexia: A randomized controlled trial. Clin. Rehabil. 2020, 34, 1391–1399. [CrossRef] 192. Lavín-Pérez, A.M.; Collado-Mateo, D.; Mayo, X.; Liguori, G.; Humphreys, L.; Copeland, R.J.; Jiménez, A. Effects of high-intensity training on the quality of life of cancer patients and survivors: A systematic review with meta-analysis. Sci. Rep. 2021, 11, 15089. [CrossRef] [PubMed] 193. Plotnikoff, R.C.; Courneya, K.S.; Trinh, L.; Karunamuni, N.; Sigal, R.J. Aerobic physical activity and resistance training: An application of the theory of planned behavior among adults with type 2 diabetes in a random, national sample of Canadians. Int. J. Behav. Nutr. Phys. Act. 2008, 5, 61. [CrossRef] 194. Cormie, P.; Pumpa, K.; Galvão, D.A.; Turner, E.; Spry, N.; Saunders, C.; Zissiadis, Y.; Newton, R.U. Is it safe and efficacious for women with lymphedema secondary to breast cancer to lift heavy weights during exercise: A randomised controlled trial. J. Cancer Surviv. 2013, 7, 413–424. [CrossRef] 195. Pedersen, B.K.; Saltin, B. Exercise as medicine—Evidence for prescribing exercise as therapy in 26 different chronic diseases. Scand. J. Med. Sci. Sport. 2015, 25, 1–72. [CrossRef] 196. Del Fabbro, E.; Orr, T.A.; Stella, S.M. Practical approaches to managing cancer patients with weight loss. Curr. Opin. Support. Palliat. Care 2017, 11, 272–277. [CrossRef] [PubMed] 197. Schmitt, J.; Lindner, N.; Reuss-Borst, M.; Holmberg, H.C.; Sperlich, B. A 3-week multimodal intervention involving high-intensity interval training in female cancer survivors: A randomized controlled trial. Physiol. Rep. 2016, 4, e12693. [CrossRef] [PubMed] 198. Adamsen, L.; Quist, M.; Andersen, C.; Møller, T.; Herrstedt, J.; Kronborg, D.; Baadsgaard, M.T.; Vistisen, K.; Midtgaard, J.; Christiansen, B.; et al. Effect of a multimodal high intensity exercise intervention in cancer patients undergoing chemotherapy: Randomised controlled trial. BMJ 2009, 339, b3410. [CrossRef] 199. Midtgaard, J.; Christensen, J.F.; Tolver, A.; Jones, L.W.; Uth, J.; Rasmussen, B.; Tang, L.; Adamsen, L.; Rørth, M. Efficacy of multimodal exercise-based rehabilitation on physical activity, cardiorespiratory fitness, and patient-reported outcomes in cancer survivors: A randomized, controlled trial. Ann. Oncol. 2013, 24, 2267–2273. [CrossRef] 200. Redondo-Flórez, L.; Ramos-Campo, D.J.; Clemente-Suárez, V.J. Body Composition, Psychological, Cardiovascular, and Physical Activity Factors Related with Academic School Performance. Sustainability 2021, 13, 8775. [CrossRef]
dc.relation.citationendpage.spa.fl_str_mv	27
dc.relation.citationstartpage.spa.fl_str_mv	1
dc.relation.citationissue.spa.fl_str_mv	8
dc.relation.citationvolume.spa.fl_str_mv	19
dc.rights.eng.fl_str_mv	Copyright 2022 Elsevier B.V., All rights reserved.
dc.rights.license.spa.fl_str_mv	Atribución 4.0 Internacional (CC BY 4.0)
dc.rights.uri.spa.fl_str_mv	https://creativecommons.org/licenses/by/4.0/
dc.rights.accessrights.spa.fl_str_mv	info:eu-repo/semantics/openAccess
dc.rights.coar.spa.fl_str_mv	http://purl.org/coar/access_right/c_abf2
rights_invalid_str_mv	Atribución 4.0 Internacional (CC BY 4.0) Copyright 2022 Elsevier B.V., All rights reserved. https://creativecommons.org/licenses/by/4.0/ http://purl.org/coar/access_right/c_abf2
eu_rights_str_mv	openAccess
dc.format.extent.spa.fl_str_mv	27 páginas
dc.format.mimetype.spa.fl_str_mv	application/pdf
dc.publisher.spa.fl_str_mv	Multidisciplinary Digital Publishing Institute (MDPI)
dc.publisher.place.spa.fl_str_mv	Switzerland
dc.source.spa.fl_str_mv	https://www.scopus.com/record/display.uri?eid=2-s2.0-85127842259&doi=10.3390%2fijerph19084604&origin=inward&txGid=b823efa14afe343715ad6fb635377d58
institution	Corporación Universidad de la Costa
bitstream.url.fl_str_mv	https://repositorio.cuc.edu.co/bitstreams/28049696-6581-4500-abe3-bec2d20cf4de/download https://repositorio.cuc.edu.co/bitstreams/d91723b8-ba14-40cc-ac6c-7f148e068309/download https://repositorio.cuc.edu.co/bitstreams/f8ced719-183e-4c69-bf95-b050fc17ef30/download https://repositorio.cuc.edu.co/bitstreams/f550f9f2-9d71-4abc-996c-45b19b5d35a2/download
bitstream.checksum.fl_str_mv	09db0739bf38d7f81203f36b1a75c848 2f9959eaf5b71fae44bbf9ec84150c7a 3ff1a4e36907439d1a8a063b475ecbdd 20735c01399b38654d6a50aec0e31ee2
bitstream.checksumAlgorithm.fl_str_mv	MD5 MD5 MD5 MD5
repository.name.fl_str_mv	Repositorio de la Universidad de la Costa CUC
repository.mail.fl_str_mv	repdigital@cuc.edu.co
_version_	1828166810066747392
spelling	Atribución 4.0 Internacional (CC BY 4.0)Copyright 2022 Elsevier B.V., All rights reserved.https://creativecommons.org/licenses/by/4.0/info:eu-repo/semantics/openAccesshttp://purl.org/coar/access_right/c_abf2Clemente-Suárez, Vicente JavierRedondo-Flórez, LauraRubio-Zarapuz, AlejandroMartínez-Guardado, IsmaelNavarro-Jiménez, EduardoTornero-Aguilera, José Francisco2024-04-04T20:03:09Z2024-04-04T20:03:09Z2022-04-11Clemente-Suárez, V.J.; Redondo-Flórez, L.; Rubio-Zarapuz, A.; Martínez-Guardado, I.; Navarro-Jiménez, E.; TorneroAguilera, J.F. Nutritional and Exercise Interventions in Cancer-Related Cachexia: An Extensive Narrative Review. Int. J. Environ. Res. Public Health 2022, 19, 4604. https://doi.org/10.3390/ijerph190846041661-7827https://hdl.handle.net/11323/1094210.3390/ijerph19084604Corporación Universidad de la CostaREDICUC - Repositorio CUChttps://repositorio.cuc.edu.coOne of the common traits found in cancer patients is malnutrition and cachexia, which affects between 25% to 60% of the patients, depending on the type of cancer, diagnosis, and treatment. Given the lack of current effective pharmacological solutions for low muscle mass and sarcopenia, holistic interventions are essential to patient care, as well as exercise and nutrition. Thus, the present narrative review aimed to analyze the nutritional, pharmacological, ergonutritional, and physical exercise strategies in cancer-related cachexia. The integration of multidisciplinary interventions could help to improve the final intervention in patients, improving their prognosis, quality of life, and life expectancy. To reach these aims, an extensive narrative review was conducted. The databases used were MedLine (PubMed), Cochrane (Wiley), Embase, PsychINFO, and CinAhl. Cancer-related cachexia is a complex multifactorial phenomenon in which systemic inflammation plays a key role in the development and maintenance of the symptomatology. Pharmacological interventions seem to produce a positive effect on inflammatory state and cachexia. Nutritional interventions are focused on a high-energy diet with high-density foods and the supplementation with antioxidants, while physical activity is focused on strength-based training. The implementation of multidisciplinary non-pharmacological interventions in cancer-related cachexia could be an important tool to improve traditional treatments and improve patients’ quality of life.27 páginasapplication/pdfengMultidisciplinary Digital Publishing Institute (MDPI)Switzerlandhttps://www.scopus.com/record/display.uri?eid=2-s2.0-85127842259&doi=10.3390%2fijerph19084604&origin=inward&txGid=b823efa14afe343715ad6fb635377d58Nutritional and exercise interventions in cancer-related cachexia: an extensive narrative reviewArtículo de revistahttp://purl.org/coar/resource_type/c_2df8fbb1Textinfo:eu-repo/semantics/articlehttp://purl.org/redcol/resource_type/ARTinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/version/c_970fb48d4fbd8a85International Journal of Environmental Research and Public Health1. Marshall, K.M.; Loeliger, J.; Nolte, L.; Kelaart, A.; Kiss, N.K. Prevalence of malnutrition and impact on clinical outcomes in cancer services: A comparison of two time points. Clin. Nutr. 2019, 38, 644–651. [CrossRef]2. Cederholm, T.; Barazzoni, R.; Austin, P.; Ballmer, P.; Biolo, G.; Bischoff, S.C.; Compher, C.; Correia, I.; Higashiguchi, T.; Holst, M.; et al. ESPEN guidelines on definitions and terminology of clinical nutrition. Clin. Nutr. 2017, 36, 49–64. [CrossRef] [PubMed]3. Bower, J.E.; Ganz, P.A.; Tao, M.L.; Hu, W.; Belin, T.R.; Sepah, S.; Cole, S.; Aziz, N. Inflammatory biomarkers and fatigue during radiation therapy for breast and prostate cancer. Clin. Cancer Res. 2009, 15, 5534–5540. [CrossRef] [PubMed]4. Bower, J.E.; Lamkin, D.M. Inflammation and cancer-related fatigue: Mechanisms, contributing factors, and treatment implications. Brain. Behav. Immun. 2013, 30, S48–S57. [CrossRef]5. Morishita, S. Prevalence of sarcopenia in cancer patients: Review and future directions. Int. J. Phys. Med. Rehabil. 2016, 4, 342. [CrossRef]6. Zhang, X.; Tang, T.; Pang, L.; Sharma, S.V.; Li, R.; Nyitray, A.G.; Edwards, B.J. Malnutrition and overall survival in older adults with cancer: A systematic review and meta-analysis. J. Geriatr. Oncol. 2019, 10, 874–883. [CrossRef]7. Wang, S.-L.; Zhuang, C.-L.; Huang, D.-D.; Pang, W.-Y.; Lou, N.; Chen, F.-F.; Zhou, C.-J.; Shen, X.; Yu, Z. Sarcopenia adversely impacts postoperative clinical outcomes following gastrectomy in patients with gastric cancer: A prospective study. Ann. Surg. Oncol. 2016, 23, 556–564. [CrossRef]8. Curtis, A.R.; Livingstone, K.M.; Daly, R.M.; Marchese, L.E.; Kiss, N. Associations between dietary patterns and malnutrition, low muscle mass and sarcopenia in adults with cancer: A scoping review. Int. J. Environ. Res. Public Health 2022, 19, 1769. [CrossRef]9. Nipp, R.D.; Fuchs, G.; El-Jawahri, A.; Mario, J.; Troschel, F.M.; Greer, J.A.; Gallagher, E.R.; Jackson, V.A.; Kambadakone, A.; Hong, T.S.; et al. Sarcopenia is associated with quality of life and depression in patients with advanced cancer. Oncologist 2018, 23, 97–104. [CrossRef]10. Baguley, B.J.; Bolam, K.A.; Wright, O.R.L.; Skinner, T.L. The effect of nutrition therapy and exercise on cancer-related fatigue and quality of life in men with prostate cancer: A systematic review. Nutrients 2017, 9, 1003. [CrossRef]11. Minnella, E.M.; Awasthi, R.; Loiselle, S.E.; Agnihotram, R.V.; Ferri, L.E.; Carli, F. Effect of exercise and nutrition prehabilitation on functional vapacity in esophagogastric cancer surgery: A randomized clinical trial. JAMA Surg. 2018, 153, 1081–1089. [CrossRef] [PubMed]12. Sadeghi, F.; Mockler, D.; Guinan, E.M.; Hussey, J.; Doyle, S.L. The effectiveness of nutrition interventions combined with exercise in upper gastrointestinal cancers: A systematic review. Nutrients 2021, 13, 2842. [CrossRef] [PubMed]13. Burden, S.; Jones, D.J.; Sremanakova, J.; Sowerbutts, A.M.; Lal, S.; Pilling, M.; Todd, C. Dietary interventions for adult cancer survivors. Cochrane Database Syst. Rev. 2019, 2019, CD011287. [CrossRef] [PubMed]14. Mefferd, K.; Nichols, J.F.; Pakiz, B.; Rock, C.L. A cognitive behavioral therapy intervention to promote weight loss improves body composition and blood lipid profiles among overweight breast cancer survivors. Breast Cancer Res. Treat. 2007, 104, 145–152. [CrossRef] [PubMed]15. Swisher, A.K.; Abraham, J.; Bonner, D.; Gilleland, D.; Hobbs, G.; Kurian, S.; Yanosik, M.A.; Vona-Davis, L. Exercise and dietary advice intervention for survivors of triple-negative breast cancer: Effects on body fat, physical function, quality of life, and adipokine profile. Support. Care Cancer 2015, 23, 2995–3003. [CrossRef]16. Demark-Wahnefried, W.; Rogers, L.Q.; Gibson, J.T.; Harada, S.; Frugé, A.D.; Oster, R.A.; Grizzle, W.E.; Norian, L.A.; Yang, E.S.; Della Manna, D.; et al. Randomized trial of weight loss in primary breast cancer: Impact on body composition, circulating biomarkers and tumor characteristics. Int. J. Cancer 2020, 146, 2784–2796. [CrossRef]17. O’Neill, L.M.; Guinan, E.; Doyle, S.L.; Bennett, A.E.; Murphy, C.; Elliott, J.A.; O’Sullivan, J.; Reynolds, J.V.; Hussey, J. The RESTORE randomized controlled trial: Impact of a multidisciplinary rehabilitative program on cardiorespiratory fitness in esophagogastric cancer survivorship. Ann. Surg. 2018, 268, 747–755. [CrossRef]18. Scott, E.; Daley, A.J.; Doll, H.; Woodroofe, N.; Coleman, R.E.; Mutrie, N.; Crank, H.; Powers, H.J.; Saxton, J.M. Effects of an exercise and hypocaloric healthy eating program on biomarkers associated with long-term prognosis after early-stage breast cancer: A randomized controlled trial. Cancer Causes Control 2013, 24, 181–191. [CrossRef]19. Fiuza-Luces, C.; Garatachea, N.; Berger, N.A.; Lucia, A. Exercise is the real polypill. Physiology 2013, 28, 330–358. [CrossRef]20. Buffart, L.M.; Galvão, D.A.; Brug, J.; Chinapaw, M.J.M.; Newton, R.U. Evidence-based physical activity guidelines for cancer survivors: Current guidelines, knowledge gaps and future research directions. Cancer Treat. Rev. 2014, 40, 327–340. [CrossRef]21. Clemente-Suárez, V.J.; Beltrán-Velasco, A.I.; Ramos-Campo, D.J.; Mielgo-Ayuso, J.; Nikolaidis, P.A.; Belando, N.; Tornero-Aguilera, J.F. Physical activity and COVID-19. The basis for an efficient intervention in times of COVID-19 pandemic. Physiol. Behav. 2022, 244, 113667. [CrossRef] [PubMed]22. Clemente-Suárez, V.J.; Ramos-Campo, D.J.; Mielgo-Ayuso, J.; Dalamitros, A.A.; Nikolaidis, P.A.; Hormeño-Holgado, A.; Tornero-Aguilera, J.F. Nutrition in the actual Covid-19 pandemic. A narrative review. Nutrients 2021, 13, 1924. [CrossRef] [PubMed]23. Clemente-Suárez, V.J.; Navarro-Jiménez, E.; Ruisoto, P.; Dalamitros, A.A.; Beltran-Velasco, A.I.; Hormeño-Holgado, A.; Laborde-Cárdenas, C.C.; Tornero-Aguilera, J.F. Performance of fuzzy multi-criteria decision analysis of emergency system in Covid-19 pandemic. An extensive narrative review. Int. J. Environ. Res. Public Health 2021, 18, 5208. [CrossRef] [PubMed]24. World Health Organization WHO Report on Cancer: Setting Priorities, Investing Wisely and Providing Care for All. Available online: https://www.who.int/publications/i/item/who-report-on-cancer-setting-priorities-investing-wisely-and-providingcare-for-all (accessed on 14 February 2022).25. Muscaritoli, M.; Lucia, S.; Farcomeni, A.; Lorusso, V.; Saracino, V.; Barone, C.; Plastino, F.; Gori, S.; Magarotto, R.; Carteni, G.; et al. Prevalence of malnutrition in patients at first medical oncology visit: The PreMiO study. Oncotarget 2017, 8, 79884–79896. [CrossRef]26. Luengo-Fernandez, R.; Leal, J.; Gray, A.; Sullivan, R. Economic burden of cancer across the European Union: A population-based cost analysis. Lancet Oncol. 2013, 14, 1165–1174. [CrossRef]27. Shpata, V.; Prendushi, X.; Kreka, M.; Kola, I.; Kurti, F.; Ohri, I. Malnutrition at the time of surgery affects negatively the clinical outcome of critically ill patients with gastrointestinal cancer. Med. Arch. 2014, 68, 263–267. [CrossRef]28. Chang, C.H.; Qiu, J.; O’Sullivan, D.; Buck, M.D.; Noguchi, T.; Curtis, J.D.; Chen, Q.; Gindin, M.; Gubin, M.M.; van der Windt, G.J.W.; et al. Metabolic competition in the tumor microenvironment is a driver of cancer progression. Cell 2015, 162, 1229–1241. [CrossRef]29. Baracos, V.E. Cancer-associated malnutrition. Eur. J. Clin. Nutr. 2018, 72, 1255–1259. [CrossRef]30. Van Cutsem, E.; Arends, J. The causes and consequences of cancer-associated malnutrition. Eur. J. Oncol. Nurs. 2005, 9 (Suppl. 2), S51–S63. [CrossRef]31. Mialich, M.S.; Sicchieri, J.M.F.; Junior, A.A.J. Analysis of body composition: A critical review of the use of bioelectrical impedance analysis. Int. J. Clin. Nutr. 2014, 2, 1–10.32. Argilés, J.M. Cancer-associated malnutrition. Eur. J. Oncol. Nurs. 2005, 9 (Suppl. 2), S39–S50. [CrossRef] [PubMed]33. Nordhausen, K.; Solass, W.; Demtroeder, C.; Tempfer, C.B.; Reymond, M. Cachexia-anorexia syndrome in patients with peritoneal metastasis: An observational study. Pleura Peritoneum 2016, 1, 57–63. [CrossRef] [PubMed]34. Mantovani, G.; Madeddu, C. Cancer cachexia: Medical management. Support. Care Cancer 2010, 18, 1–9. [CrossRef] [PubMed]35. Vander Heiden, M.G.; Cantley, L.C.; Thompson, C.B. Understanding the Warburg Effect: The metabolic requirements of cell proliferation. Science 2009, 324, 1029–1033. [CrossRef]36. Argilés, J.M.; Campos, N.; Lopez-Pedrosa, J.M.; Rueda, R.; Rodriguez-Mañas, L. Skeletal Muscle regulates metabolism via interorgan crosstalk: Roles in health and disease. J. Am. Med. Dir. Assoc. 2016, 17, 789–796. [CrossRef]37. Da Fonseca, G.W.P.; Farkas, J.; Dora, E.; von Haehling, S.; Lainscak, M. Cancer cachexia and related metabolic dysfunction. Int. J. Mol. Sci. 2020, 21, 2321. [CrossRef]38. Ebadi, M.; Mazurak, V.C. Evidence and mechanisms of fat depletion in cancer. Nutrients 2014, 6, 5280–5297. [CrossRef]39. Agustsson, T.; Rydén, M.; Hoffstedt, J.; van Harmelen, V.; Dicker, A.; Laurencikiene, J.; Isaksson, B.; Permert, J.; Arner, P. Mechanism of increased lipolysis in cancer cachexia. Cancer Res. 2007, 67, 5531–5537. [CrossRef]40. Mracek, T.; Stephens, N.A.; Gao, D.; Bao, Y.; Ross, J.A.; Rydén, M.; Arner, P.; Trayhurn, P.; Fearon, K.C.H.; Bing, C. Enhanced ZAG production by subcutaneous adipose tissue is linked to weight loss in gastrointestinal cancer patients. Br. J. Cancer 2011, 104, 441–447. [CrossRef]41. Russell, S.T.; Hirai, K.; Tisdale, M.J. Role of β3-adrenergic receptors in the action of a tumour lipid mobilizing factor. Br. J. Cancer 2002, 86, 424–428. [CrossRef]42. Cero, C.; Lea, H.J.; Zhu, K.Y.; Shamsi, F.; Tseng, Y.H.; Cypess, A.M. β3 -Adrenergic receptors regulate human brown/beige adipocyte lipolysis and thermogenesis. JCI Insight 2021, 6. [CrossRef]43. Elattar, S.; Dimri, M.; Satyanarayana, A. The tumor secretory factor ZAG promotes white adipose tissue browning and energy wasting. FASEB J. 2018, 32, 4727–4743. [CrossRef] [PubMed]44. Dev, R.; Bruera, E.; Dalal, S. Insulin resistance and body composition in cancer patients. Ann. Oncol. 2018, 29 (Suppl. 2), ii18–ii26. [CrossRef]45. Fearon, K.C.H.; Glass, D.J.; Guttridge, D.C. Cancer cachexia: Mediators, signaling, and metabolic pathways. Cell Metab. 2012, 16, 153–166. [CrossRef]46. Han, J.; Meng, Q.; Shen, L.; Wu, G. Interleukin-6 induces fat loss in cancer cachexia by promoting white adipose tissue lipolysis and browning. Lipids Health Dis. 2018, 17, 14. [CrossRef] [PubMed]47. Vegiopoulos, A.; Rohm, M.; Herzig, S. Adipose tissue: Between the extremes. EMBO J. 2017, 36, 1999–2017. [CrossRef] [PubMed]48. Rofe, A.M.; Bourgeois, C.S.; Coyle, P.; Taylor, A.; Abdi, E.A. Altered insulin response to glucose in weight-losing cancer patients. Anticancer Res. 1994, 14, 647–650.49. Burns, J.S.; Manda, G. Metabolic pathways of thewarburg effect in health and disease: Perspectives of choice, chain or chance. Int. J. Mol. Sci. 2017, 18, 2755. [CrossRef]50. MacAdams, J.; Winter, A.; Morais, J.A.; Burgess, S.C.; Chevalier, S. Elevated gluconeogenesis in aging and lung cancer is related to inflammation and blunted insulin-induced protein anabolism. FASEB J. 2013, 27, 1074.10. [CrossRef]51. Armstrong, V.S.; Fitzgerald, L.W.; Bathe, O.F. Cancer-associated muscle wasting—candidate mechanisms and molecular pathways. Int. J. Mol. Sci. 2020, 21, 9268. [CrossRef]52. Koyama, S.; Hata, S.; Witt, C.C.; Ono, Y.; Lerche, S.; Ojima, K.; Chiba, T.; Doi, N.; Kitamura, F.; Tanaka, K.; et al. Muscle RING-Finger Protein-1 (MuRF1) as a connector of muscle energy metabolism and protein synthesis. J. Mol. Biol. 2008, 376, 1224–1236. [CrossRef] [PubMed]53. Witt, S.H.; Granzier, H.; Witt, C.C.; Labeit, S. MURF-1 and MURF-2 target a specific subset of myofibrillar proteins redundantly: Towards understanding MURF-dependent muscle ubiquitination. J. Mol. Biol. 2005, 350, 713–722. [CrossRef] [PubMed]54. Fielitz, J.; Kim, M.S.; Shelton, J.M.; Latif, S.; Spencer, J.A.; Glass, D.J.; Richardson, J.A.; Bassel-Duby, R.; Olson, E.N. Myosin accumulation and striated muscle myopathy result from the loss of muscle RING finger 1 and 3. J. Clin. Investig. 2007, 117, 2486–2495. [CrossRef] [PubMed]55. Bodine, S.C.; Baehr, L.M. Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx/atrogin-1. Am. J. Physiol. Endocrinol. Metab. 2014, 307, E469–E484. [CrossRef] [PubMed]56. Adams, V.; Mangner, N.; Gasch, A.; Krohne, C.; Gielen, S.; Hirner, S.; Thierse, H.J.; Witt, C.C.; Linke, A.; Schuler, G.; et al. Induction of MuRF1 is essential for TNF-α-induced loss of muscle function in mice. J. Mol. Biol. 2008, 384, 48–59. [CrossRef]57. Li, H.; Malhotra, S.; Kumar, A. Nuclear factor-kappa B signaling in skeletal muscle atrophy. J. Mol. Med. 2008, 86, 1113–1126. [CrossRef]58. Zhao, J.; Brault, J.J.; Schild, A.; Cao, P.; Sandri, M.; Schiaffino, S.; Lecker, S.H.; Goldberg, A.L. FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells. Cell Metab. 2007, 6, 472–483. [CrossRef]59. Dogra, C.; Changoua, H.; Wedhas, N.; Qin, X.; Wergedal, J.E.; Kumar, A. TNF-related weak inducer of apoptosis (TWEAK) is a potent skeletal muscle-wasting cytokine. FASEB J. 2007, 21, 1857–1869. [CrossRef]60. Stitt, T.N.; Drujan, D.; Clarke, B.A.; Panaro, F.; Timofeyva, Y.; Kline, W.O.; Gonzalez, M.; Yancopoulos, G.D.; Glass, D.J. The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol. Cell 2004, 14, 395–403. [CrossRef]61. García-Prat, L.; Perdiguero, E.; Alonso-Martín, S.; Dell’Orso, S.; Ravichandran, S.; Brooks, S.R.; Juan, A.H.; Campanario, S.; Jiang, K.; Hong, X.; et al. FoxO maintains a genuine muscle stem-cell quiescent state until geriatric age. Nat. Cell Biol. 2020, 22, 1307–1318. [CrossRef]62. Huang, X.Y.; Huang, Z.L.; Yang, J.H.; Xu, Y.H.; Sun, J.S.; Zheng, Q.; Wei, C.; Song, W.; Yuan, Z. Pancreatic cancer cell-derived IGFBP-3 contributes to muscle wasting. J. Exp. Clin. Cancer Res. 2016, 35, 46. [CrossRef] [PubMed]63. Salih, D.A.M.; Tripathi, G.; Holding, C.; Szestak, T.A.M.; Gonzalez, M.I.; Carter, E.J.; Cobb, L.J.; Eisemann, J.E.; Pell, J.M. Insulinlike growth factor-binding protein 5 (Igfbp5) compromises survival, growth, muscle development, and fertility in mice. Proc. Natl. Acad. Sci. USA 2004, 101, 4314–4319. [CrossRef] [PubMed]64. Wang, F.; Liu, H.; Hu, L.; Liu, Y.; Duan, Y.; Cui, R.; Tian, W. The Warburg Effect in human pancreatic cancer cells triggers cachexia in athymic mice carrying the cancer cells. BMC Cancer 2018, 18, 360. [CrossRef] [PubMed]65. John, A.P. Dysfunctional mitochondria, not oxygen insufficiency, cause cancer cells to produce inordinate amounts of lactic acid: The impact of this on the treatment of cancer. Med. Hypotheses 2001, 57, 429–431. [CrossRef]66. Hainerová, I.A.; Lebl, J. Mechanisms of appetite regulation. J. Pediatr. Gastroenterol. Nutr. 2010, 51 (Suppl. 3), S123–S124. [CrossRef]67. Ruiz Garcia, V.; López-Briz, E.; Carbonell Sanchis, R.; Gonzalvez Perales, J.L.; Bort-Marti, S. Megestrol acetate for treatment of anorexia-cachexia syndrome. Cochrane Database Syst. Rev. 2013, 2013, CD004310. [CrossRef]68. Jatoi, A.; Windschitl, H.E.; Loprinzi, C.L.; Sloan, J.A.; Dakhil, S.R.; Mailliard, J.A.; Pundaleeka, S.; Kardinal, C.G.; Fitch, T.R.; Krook, J.E.; et al. Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: A north central cancer treatment group study. J. Clin. Oncol. 2002, 20, 567–573. [CrossRef]69. Fatima, K.; Andleeb, A.; Hussain, I.; Sofi, M.A.; Fir, A.; Qadri, S.K. Megestrol acetate in cancer cachexia and anorexia: Tertiary care experience. J. Radiat. Cancer Res. 2021, 12, 168–171. [CrossRef]70. Brisbois, T.D.; de Kock, I.H.; Watanabe, S.M.; Mirhosseini, M.; Lamoureux, D.C.; Chasen, M.; MacDonald, N.; Baracos, V.E.; Wismer, W. V Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: Results of a randomized, double-blind, placebo-controlled pilot trial. Ann. Oncol. 2011, 22, 2086–2093. [CrossRef]71. Johnson, J.R.; Burnell-Nugent, M.; Lossignol, D.; Ganae-Motan, E.D.; Potts, R.; Fallon, M.T. Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain. J. Pain Symptom Manag. 2010, 39, 167–179. [CrossRef]72. Yavuzsen, T.; Davis, M.P.; Walsh, D.; LeGrand, S.; Lagman, R. Systematic review of the treatment of cancer-associated anorexia and weight loss. J. Clin. Oncol. 2005, 23, 8500–8511. [CrossRef] [PubMed]73. Liu, D.; Ahmet, A.; Ward, L.; Krishnamoorthy, P.; Mandelcorn, E.D.; Leigh, R.; Brown, J.P.; Cohen, A.; Kim, H. A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy. Allergy Asthma Clin. Immunol. 2013, 9, 30. [CrossRef] [PubMed]74. Gasco, V.; Beccuti, G.; Marotta, F.; Benso, A.; Granata, R.; Broglio, F.; Ghigo, E. Endocrine and metabolic actions of ghrelin. In Pediatric Neuroendocrinology; Loche, S., Cappa, M., Ghizzoni, L., Maghnie, M., Savage, M.O., Eds.; Endocrine Development; Karger: Basel, Switzerland, 2010; Volume 17, pp. 86–95. [CrossRef]75. Lim, C.T.; Kola, B.; Korbonits, M.; Grossman, A.B. Ghrelin’s role as a major regulator of appetite and its other functions in neuroendocrinology. Prog. Brain Res. 2010, 182, 189–205. [CrossRef]76. Chen, J.A.; Splenser, A.; Guillory, B.; Luo, J.; Mendiratta, M.; Belinova, B.; Halder, T.; Zhang, G.; Li, Y.P.; Garcia, J.M. Ghrelin prevents tumour- and cisplatin-induced muscle wasting: Characterization of multiple mechanisms involved. J. Cachexia Sarcopenia Muscle 2015, 6, 132–143. [CrossRef] [PubMed]77. Temel, J.S.; Abernethy, A.P.; Currow, D.C.; Friend, J.; Duus, E.M.; Yan, Y.; Fearon, K.C. Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): Results from two randomised, double-blind, phase 3 trials. Lancet Oncol. 2016, 17, 519–531. [CrossRef]78. Malik, J.S.; Yennurajalingam, S. Prokinetics and ghrelin for the management of cancer cachexia syndrome. Ann. Palliat. Med. 2019, 8, 80–85. [CrossRef]79. Suzuki, H.; Asakawa, A.; Amitani, H.; Nakamura, N.; Inui, A. Cancer cachexia—Pathophysiology and management. J. Gastroenterol. 2013, 48, 574–594. [CrossRef]80. Singh, N.; Baby, D.; Rajguru, J.P.; Patil, P.B.; Thakkannavar, S.S.; Pujari, V.B. Inflammation and cancer. Ann. Afr. Med. 2019, 18, 121–126. [CrossRef]81. Al-Zhoughbi, W.; Huang, J.; Paramasivan, G.S.; Till, H.; Pichler, M.; Guertl-Lackner, B.; Hoefler, G. Tumor macroenvironment and metabolism. Semin. Oncol. 2014, 41, 281–295. [CrossRef]82. Ni, J.; Zhang, L. Cancer cachexia: Definition, staging, and emerging treatments. Cancer Manag. Res. 2020, 12, 5597–5605. [CrossRef]83. Schuster, M.; Rigas, J.R.; Orlov, S.V.; Milovanovic, B.; Prabhash, K.; Smith, J.T. ALD518, a humanized anti-IL-6 antibody, treats anemia in patients with advanced non-small cell lung cancer (NSCLC): Results of a phase II, randomized, double-blind, placebo-controlled trial. J. Clin. Oncol. 2010, 28, 7631. [CrossRef]84. Chauhan, A.; Sequeria, A.; Manderson, C.; Maddocks, M.; Wasley, D.; Wilcock, A. Exploring autonomic nervous system dysfunction in patients with cancer cachexia: A pilot study. Auton. Neurosci. Basic Clin. 2012, 166, 93–95. [CrossRef] [PubMed]85. Trobec, K.; Palus, S.; Tschirner, A.; von Haehling, S.; Doehner, W.; Lainscak, M.; Anker, S.D.; Springer, J. Rosiglitazone reduces body wasting and improves survival in a rat model of cancer cachexia. Nutrition 2014, 30, 1069–1075. [CrossRef] [PubMed]86. Auger, C.; Knuth, C.M.; Abdullahi, A.; Samadi, O.; Parousis, A.; Jeschke, M.G. Metformin prevents the pathological browning of subcutaneous white adipose tissue. Mol. Metab. 2019, 29, 12–23. [CrossRef] [PubMed]87. Oliveira, A.G.; Gomes-Marcondes, M.C.C. Metformin treatment modulates the tumour-induced wasting effects in muscle protein metabolism minimising the cachexia in tumour-bearing rats. BMC Cancer 2016, 16, 418. [CrossRef]88. Lainscak, M.; Laviano, A. ACT-ONE - ACTION at last on cancer cachexia by adapting a novel action beta-blocker. J. Cachexia Sarcopenia Muscle 2016, 7, 400–402. [CrossRef]89. von Haehling, S.; Lainscak, M.; Springer, J.; Anker, S.D. Cardiac cachexia: A systematic overview. Pharmacol. Ther. 2009, 121, 227–252. [CrossRef]90. Pötsch, M.S.; Tschirner, A.; Palus, S.; von Haehling, S.; Doehner, W.; Beadle, J.; Coats, A.J.S.; Anker, S.D.; Springer, J. The anabolic catabolic transforming agent (ACTA) espindolol increases muscle mass and decreases fat mass in old rats. J. Cachexia Sarcopenia Muscle 2014, 5, 149–158. [CrossRef]91. Stewart Coats, A.J.; Ho, G.F.; Prabhash, K.; von Haehling, S.; Tilson, J.; Brown, R.; Beadle, J.; Anker, S.D. Espindolol for the treatment and prevention of cachexia in patients with stage III/IV non-small cell lung cancer or colorectal cancer: A randomized, double-blind, placebo-controlled, international multicentre phase II study (the ACT-ONE trial). J. Cachexia Sarcopenia Muscle 2016, 7, 355–365. [CrossRef]92. Pleadin, J.; Vuli´c, A.; Perši, N. β-adrenergic agonists: Substances with anabolic effect in animals for meat production. MESO 2012, 14, 80–87.93. World Health Organization Nutrition. Available online: https://www.who.int/health-topics/nutrition (accessed on 14 February 2022).94. Ravasco, P. Nutrition in cancer patients. J. Clin. Med. 2019, 8, 1211. [CrossRef] [PubMed]95. Donaldson, M.S. Nutrition and cancer: A review of the evidence for an anti-cancer diet. Nutr. J. 2004, 3, 19. [CrossRef] [PubMed]96. Preiser, J.C.; Schneider, S.M. ESPEN disease-specific guideline framework. Clin. Nutr. 2011, 30, 549–552. [CrossRef]97. Martin, L.; Senesse, P.; Gioulbasanis, I.; Antoun, S.; Bozzetti, F.; Deans, C.; Strasser, F.; Thoresen, L.; Jagoe, R.T.; Chasen, M.; et al. Diagnostic criteria for the classification of cancer-associated weight loss. J. Clin. Oncol. 2015, 33, 90–99. [CrossRef] [PubMed]98. Bozzetti, F.; Arends, J.; Lundholm, K.; Micklewright, A.; Zurcher, G.; Muscaritoli, M. ESPEN guidelines on parenteral nutrition: Non-surgical oncology. Clin. Nutr. 2009, 28, 445–454. [CrossRef] [PubMed]99. Rossi-Fanelli, F.; Franchi, F.; Mulieri, M.; Cangiano, C.; Cascino, A.; Ceci, F.; Muscaritoli, M.; Seminara, P.; Bonomo, L. Effect of energy substrate manipulation on tumour cell proliferation in parenterally fed cancer patients. Clin. Nutr. 1991, 10, 228–232. [CrossRef]100. Bossola, M.; Pacelli, F.; Rosa, F.; Tortorelli, A.; Battista Doglietto, G. Does nutrition support stimulate tumor growth in humans? Nutr. Clin. Pract. 2011, 26, 174–180. [CrossRef]101. Warner, E.L.; Waters, A.R.; Cloyes, K.G.; Ellington, L.; Kirchhoff, A.C. Young adult cancer caregivers’ exposure to cancer misinformation on social media. Cancer 2021, 127, 1318–1324. [CrossRef]102. Arends, J.; Bachmann, P.; Baracos, V.; Barthelemy, N.; Bertz, H.; Bozzetti, F.; Fearon, K.; Hütterer, E.; Isenring, E.; Kaasa, S.; et al. ESPEN guidelines on nutrition in cancer patients. Clin. Nutr. 2017, 36, 11–48. [CrossRef]103. Baracos, V.E. Skeletal muscle anabolism in patients with advanced cancer. Lancet Oncol. 2014, 16, 13–14. [CrossRef]104. Nitenberg, G.; Raynard, B. Nutritional support of the cancer patient: Issues and dilemmas. Crit. Rev. Oncol. Hematol. 2000, 34, 137–168. [CrossRef]105. Barrera, R. Nutritional support in cancer patients. J. Parenter. Enter. Nutr. 2002, 26, S63–S71. [CrossRef] [PubMed]106. Baracos, V.E. Meeting the amino acid requirements for protein anabolism in cancer cachexia. In Cachexia and Wasting: A Modern Approach; Mantovani, G., Anker, S.D., Inui, A., Morley, J.E., Fanelli, F.R., Scevola, D., Schuster, M.W., Yeh, S.-S., Eds.; Springer: Milan, Italy, 2006; pp. 631–634.107. Bozzetti, F.; Bozzetti, V. Is the intravenous supplementation of amino acid to cancer patients adequate? A critical appraisal of literature. Clin. Nutr. 2013, 32, 142–146. [CrossRef] [PubMed]108. Haran, P.H.; Rivas, D.A.; Fielding, R.A. Role and potential mechanisms of anabolic resistance in sarcopenia. J. Cachexia Sarcopenia Muscle 2012, 3, 157–162. [CrossRef]109. Winter, A.; MacAdams, J.; Chevalier, S. Normal protein anabolic response to hyperaminoacidemia in insulin-resistant patients with lung cancer cachexia. Clin. Nutr. 2012, 31, 765–773. [CrossRef]110. Cano, N.; Fiaccadori, E.; Tesinsky, P.; Toigo, G.; Druml, W.; Kuhlmann, M.; Mann, H.; Hörl, W.H. ESPEN guidelines on enteral nutrition: Adult renal failure. Clin. Nutr. 2006, 25, 295–310. [CrossRef]111. Arcidiacono, B.; Iiritano, S.; Nocera, A.; Possidente, K.; Nevolo, M.T.; Ventura, V.; Foti, D.; Chiefari, E.; Brunetti, A. Insulin resistance and cancer risk: An overview of the pathogenetic mechanisms. Exp. Diabetes Res. 2012, 2012, 789174. [CrossRef] [PubMed]112. Cai, H.; Sobue, T.; Kitamura, T.; Ishihara, J.; Nanri, A.; Mizoue, T.; Iwasaki, M.; Yamaji, T.; Inoue, M.; Tsugane, S.; et al. Lowcarbohydrate diet and risk of cancer incidence: The Japan Public Health Center-based prospective study. Cancer Sci. 2022, 113, 744–755. [CrossRef] [PubMed]113. Breitkreutz, R.; Tesdal, K.; Jentschura, D.; Haas, O.; Leweling, H.; Holm, E. Effects of a high-fat diet on body composition in cancer patients receiving chemotherapy: A randomized controlled study. Wiener klinische Wochenschrift 2005, 117, 685–692. [CrossRef]114. Mamede, A.C.; Tavares, S.D.; Abrantes, A.M.; Trindade, J.; Maia, J.M.; Botelho, M.F. The role of vitamins in cancer: A review. Nutr. Cancer 2011, 63, 479–494. [CrossRef]115. Giovannucci, E.; Chan, A.T. Role of vitamin and mineral supplementation and aspirin use in cancer survivors. J. Clin. Oncol. 2010, 28, 4081–4085. [CrossRef] [PubMed]116. Food and Agricultural Organization Nutrition. Available online: https://www.fao.org/nutrition/requirements/es/ (accessed on 14 February 2022).117. Biesalski, H.-K. Mikronährstoffsupplemente bei onkologischen patienten. Der Onkologe 2008, 14, 45–57. [CrossRef]118. Zürcher, G.; Gola, U.; Biesalski, H.K. Antioxidanzien bei krebs. Schweizer Zeitschrift für Ernährungsmedizin 2007, 4, 17e9.119. Norman, H.A.; Butrum, R.R.; Feldman, E.; Heber, D.; Nixon, D.; Picciano, M.F.; Rivlin, R.; Simopoulos, A.; Wargovich, M.J.; Weisburger, E.K.; et al. The role of dietary supplements during cancer therapy. J. Nutr. 2003, 133, 3794S–3799S. [CrossRef]120. Huebner, J.; Marienfeld, S.; Abbenhardt, C.; Ulrich, C.; Muenstedt, K.; Micke, O.; Muecke, R.; Loeser, C. Counseling patients on cancer diets: A review of the literature and recommendations for clinical practice. Anticancer Res. 2014, 34, 39–48.121. Allen, B.G.; Bhatia, S.K.; Buatti, J.M.; Brandt, K.E.; Lindholm, K.E.; Button, A.M.; Szweda, L.I.; Smith, B.J.; Spitz, D.R.; Fath, M.A. Ketogenic diets enhance oxidative stress and radio-chemo-therapy responses in lung cancer xenografts. Clin. Cancer Res. 2013, 19, 3905–3913. [CrossRef]122. Bozzetti, F.; Zupec-Kania, B. Toward a cancer-specific diet. Clin. Nutr. 2016, 35, 1188–1195. [CrossRef]123. Elstrom, R.L.; Bauer, D.E.; Buzzai, M.; Karnauskas, R.; Harris, M.H.; Plas, D.R.; Zhuang, H.; Cinalli, R.M.; Alavi, A.; Rudin, C.M.; et al. Akt stimulates aerobic glycolysis in cancer cells. Cancer Res. 2004, 64, 3892–3899. [CrossRef]124. Poff, A.M.; Ari, C.; Seyfried, T.N.; D’Agostino, D.P. The Ketogenic Diet and Hyperbaric Oxygen Therapy Prolong Survival in Mice with Systemic Metastatic Cancer. PLoS ONE 2013, 8, e65522. [CrossRef]125. Bozzetti, F.; Santarpia, L.; Pironi, L.; Thul, P.; Klek, S.; Gavazzi, C.; Tinivella, M.; Joly, F.; Jonkers, C.; Baxter, J.; et al. The prognosis of incurable cachectic cancer patients on home parenteral nutrition: A multi-centre observational study with prospective follow-up of 414 patients. Ann. Oncol. 2014, 25, 487–493. [CrossRef]126. Brennan, M.F.; Pisters, P.W.; Posner, M.; Quesada, O.; Shike, M. A prospective randomized trial of total parenteral nutrition after major pancreatic resection for malignancy. Ann. Surg. 1994, 220, 436–444. [CrossRef] [PubMed]127. Scolapio, J.S.; Ukleja, A.; Burnes, J.U.; Kelly, D.G. Outcome of patients with radiation enteritis treated with home parenteral nutrition. Am. J. Gastroenterol. 2002, 97, 662–666. [CrossRef] [PubMed]128. Staun, M.; Pironi, L.; Bozzetti, F.; Baxter, J.; Forbes, A.; Joly, F.; Jeppesen, P.; Moreno, J.; Hébuterne, X.; Pertkiewicz, M.; et al. ESPEN guidelines on parenteral nutrition: Home parenteral nutrition (HPN) in adult patients. Clin. Nutr. 2009, 28, 467–479. [CrossRef] [PubMed]129. Binns, C.W.; Lee, M.K.; Lee, A.H. Problems and prospects: Public health regulation of dietary supplements. Annu. Rev. Public Health 2018, 39, 403–420. [CrossRef]130. Maughan, R.J.; Burke, L.M.; Dvorak, J.; Larson-Meyer, D.E.; Peeling, P.; Phillips, S.M.; Rawson, E.S.; Walsh, N.P.; Garthe, I.; Geyer, H.; et al. IOC consensus statement: Dietary supplements and the high-performance athlete. Int. J. Sport Nutr. Exerc. Metab. 2018, 28, 104–125. [CrossRef]131. Kami ´nski, M.; Kr˛egielska-Narozna, M.; Bogda ´nski, P. Determination of the popularity of dietary supplements using google search ˙ rankings. Nutrients 2020, 12, 908. [CrossRef] [PubMed]132. Aysin, E.; Urhan, M. Dramatic increase in dietary supplement use during Covid-19. Curr. Dev. Nutr. 2021, 5, 207. [CrossRef]133. Garthe, I.; Maughan, R.J. Athletes and supplements: Prevalence and perspectives. Int. J. Sport Nutr. Exerc. Metab. 2018, 28, 126–138. [CrossRef]134. Adami, P.E.; Koutlianos, N.; Baggish, A.; Bermon, S.; Cavarretta, E.; Deligiannis, A.; Furlanello, F.; Kouidi, E.; Marques-Vidal, P.; Niebauer, J.; et al. Cardiovascular effects of doping substances, commonly prescribed medications and ergogenic aids in relation to sports: A position statement of the sport cardiology and exercise nucleus of the European Association of Preventive Cardiology. Eur. J. Prev. Cardiol. 2022, 29, 559–575. [CrossRef]135. Tayek, J.A.; Bistrian, B.R.; Hehir, D.J.; Martin, R.; Moldawer, L.L.; Blackburn, G.L. Improved protein kinetics and albumin synthesis by branched chain amino acid-enriched total parenteral nutrition in cancer cachexia: A prospective randomized crossover trial. Cancer 1986, 58, 147–157. [CrossRef]136. Hunter, D.C.; Weintraub, M.; Blackburn, G.L.; Bistrian, B.R. Branched chain amino acids as the protein component of parenteral nutrition in cancer cachexia. Br. J. Surg. 1989, 76, 149–153. [CrossRef] [PubMed]137. Deutz, N.E.P.; Safar, A.; Schutzler, S.; Memelink, R.; Ferrando, A.; Spencer, H.; van Helvoort, A.; Wolfe, R.R. Muscle protein synthesis in cancer patients can be stimulated with a specially formulated medical food. Clin. Nutr. 2011, 30, 759–768. [CrossRef]138. Tydeman-Edwards, R. Glutamine and its use in selected oncology settings. S. Afr. J. Clin. Nutr. 2017, 30, 109–117. [CrossRef]139. Cruz-Jentoft, A.J. Beta-hydroxy-beta-methyl butyrate (HMB): From experimental data to clinical evidence in sarcopenia. Curr. Protein Pept. Sci. 2018, 19, 668–672. [CrossRef] [PubMed]140. Akutsu, Y.; Kono, T.; Uesato, M.; Hoshino, I.; Murakami, K.; Fujishiro, T.; Imanishi, S.; Endo, S.; Toyozumi, T.; Matsubara, H. Are additional trace elements necessary in total parenteral nutrition for patients with esophageal cancer receiving cisplatin-based chemotherapy? Biol. Trace Elem. Res. 2012, 150, 109–115. [CrossRef]141. Rock, C.L.; Doyle, C.; Demark-Wahnefried, W.; Meyerhardt, J.; Courneya, K.S.; Schwartz, A.L.; Bandera, E.V.; Hamilton, K.K.; Grant, B.; McCullough, M.; et al. Nutrition and physical activity guidelines for cancer survivors. CA Cancer J. Clin. 2012, 62, 242–274. [CrossRef]142. Horneber, M.; Bueschel, G.; Dennert, G.; Less, D.; Ritter, E.; Zwahlen, M. How many cancer patients use complementary and alternative medicine: A systematic review and metaanalysis. Integr. Cancer Ther. 2012, 11, 187–203. [CrossRef]143. Bjelakovic, G.; Nikolova, D.; Gluud, L.L.; Simonetti, R.G.; Gluud, C. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: Systematic review and meta-analysis. JAMA 2007, 297, 842–857. [CrossRef]144. Lawson, K.A.; Wright, M.E.; Subar, A.; Mouw, T.; Hollenbeck, A.; Schatzkin, A.; Leitzmann, M.F. Multivitamin use and risk of prostate cancer in the national institutes of health—AARP diet and health study. J. Natl. Cancer Inst. 2007, 99, 754–764. [CrossRef]145. Higgins, M.R.; Izadi, A.; Kaviani, M. Antioxidants and exercise performance: With a focus on vitamin E and C supplementation. Int. J. Environ. Res. Public Health 2020, 17, 8452. [CrossRef]146. Ristow, M.; Zarse, K.; Oberbach, A.; Klöting, N.; Birringer, M.; Kiehntopf, M.; Stumvoll, M.; Kahn, C.R.; Blüher, M. Antioxidants prevent health-promoting effects of physical exercise in humans. Proc. Natl. Acad. Sci. USA 2009, 106, 8665–8670. [CrossRef] [PubMed]147. The Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group. The Effect of Vitamin E and Beta Carotene on the Incidence of Lung Cancer and Other Cancers in Male Smokers. N. Engl. J. Med. 1994, 330, 1029–1035. [CrossRef] [PubMed]148. Klein, E.A.; Thompson, I.M.; Tangen, C.M.; Crowley, J.J.; Lucia, M.S.; Goodman, P.J.; Minasian, L.M.; Ford, L.G.; Parnes, H.L.; Gaziano, J.M.; et al. Vitamin E and the risk of prostate cancer: The Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 2011, 306, 1549–1556. [CrossRef] [PubMed]149. Kenfield, S.A.; Van Blarigan, E.L.; DuPre, N.; Stampfer, M.J.; Giovannucci, E.L.; Chan, J.M. Selenium supplementation and prostate cancer mortality. J. Natl. Cancer Inst. 2015, 107, dju360. [CrossRef] [PubMed]150. Wang, L.; Sesso, H.D.; Glynn, R.J.; Christen, W.G.; Bubes, V.; Manson, J.E.; Buring, J.E.; Gaziano, J.M. Vitamin E and C supplementation and risk of cancer in men: Posttrial follow-up in the Physicians’ Health Study II randomized trial. Am. J. Clin. Nutr. 2014, 100, 915–923. [CrossRef]151. Konopka, A.R.; Harber, M.P. Skeletal muscle hypertrophy after aerobic exercise training. Exerc. Sport Sci. Rev. 2014, 42, 53–61. [CrossRef]152. Garber, C.E.; Blissmer, B.; Deschenes, M.R.; Franklin, B.A.; Lamonte, M.J.; Lee, I.M.; Nieman, D.C.; Swain, D.P. American college of sports medicine position stand. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: Guidance for prescribing exercise. Med. Sci. Sports Exerc. 2011, 43, 1334–1359. [CrossRef]153. Grgic, J.; Mcllvenna, L.C.; Fyfe, J.J.; Sabol, F.; Bishop, D.J.; Schoenfeld, B.J.; Pedisic, Z. Does aerobic training promote the same skeletal muscle hypertrophy as resistance training? A systematic review and meta-analysis. Sport. Med. 2019, 49, 233–254. [CrossRef]154. Konopka, A.R.; Douglass, M.D.; Kaminsky, L.A.; Jemiolo, B.; Trappe, T.A.; Trappe, S.; Harber, M.P. Molecular adaptations to aerobic exercise training in skeletal muscle of older women. J. Gerontol. A. Biol. Sci. Med. Sci. 2010, 65A, 1201–1207. [CrossRef]155. Konopka, A.R.; Suer, M.K.; Wolff, C.A.; Harber, M.P. Markers of human skeletal muscle mitochondrial biogenesis and quality control: Effects of age and aerobic exercise training. J. Gerontol. A. Biol. Sci. Med. Sci. 2014, 69, 371–378. [CrossRef]156. Short, K.R.; Vittone, J.L.; Bigelow, M.L.; Proctor, D.N.; Nair, K.S. Age and aerobic exercise training effects on whole body and muscle protein metabolism. Am. J. Physiol. Endocrinol. Metab. 2004, 286, E92–E101. [CrossRef] [PubMed]157. Morinaga, M.; Sako, N.; Isobe, M.; Lee-Hotta, S.; Sugiura, H.; Kametaka, S. Aerobic exercise ameliorates cancer cachexia-induced muscle wasting through adiponectin signaling. Int. J. Mol. Sci. 2021, 22, 3110. [CrossRef] [PubMed]158. Hardee, J.P.; Montalvo, R.N.; Carson, J.A. Linking cancer cachexia-induced anabolic resistance to skeletal muscle oxidative metabolism. Oxid. Med. Cell. Longev. 2017, 2017, 8018197. [CrossRef] [PubMed]159. Pigna, E.; Berardi, E.; Aulino, P.; Rizzuto, E.; Zampieri, S.; Carraro, U.; Kern, H.; Merigliano, S.; Gruppo, M.; Mericskay, M.; et al. Aerobic Exercise and Pharmacological Treatments Counteract Cachexia by Modulating Autophagy in Colon Cancer. Sci. Rep. 2016, 6, 26991. [CrossRef]160. Ballarò, R.; Penna, F.; Pin, F.; Gómez-Cabrera, M.C.; Viña, J.; Costelli, P. Moderate exercise improves experimental cancer cachexia by modulating the redox homeostasis. Cancers 2019, 11, 285. [CrossRef]161. Niels, T.; Tomanek, A.; Freitag, N.; Schumann, M. Can Exercise Counteract Cancer Cachexia? A Systematic Literature Review and Meta-Analysis. Integr. Cancer Ther. 2020, 19, 1–14. [CrossRef]162. Khamoui, A.V.; Park, B.S.; Kim, D.H.; Yeh, M.C.; Oh, S.L.; Elam, M.L.; Jo, E.; Arjmandi, B.H.; Salazar, G.; Grant, S.C.; et al. Aerobic and resistance training dependent skeletal muscle plasticity in the colon-26 murine model of cancer cachexia. Metabolism 2016, 65, 685–698. [CrossRef]163. Gholamian, S.; Hosseini, S.R.A.; Rashidlamir, A.; Aghaalinejad, H. The effects of interval aerobic training on mesenchymal biomarker gene expression, the rate of tumor volume, and cachexia in mice with breast cancer. Iran. J. Basic Med. Sci. 2020, 23, 244–250. [CrossRef]164. Molanouri Shamsi, M.; Chekachak, S.; Soudi, S.; Quinn, L.S.; Rangbar, K.; Chenari, J.; Yazdi, M.H.; Mahdavi, M. Combined effect of aerobic interval training and selenium nanoparticles on expression of IL-15 and IL-10/TNF-α ratio in skeletal muscle of 4T1 breast cancer mice with cachexia. Cytokine 2017, 90, 100–108. [CrossRef]165. Moreira, V.M.; da Silva Franco, C.C.; Prates, K.V.; Gomes, R.M.; de Moraes, A.M.P.; Ribeiro, T.A.; Martins, I.P.; Previate, C.; Pavanello, A.; Matiusso, C.C.I.; et al. Aerobic exercise training attenuates tumor growth and reduces insulin secretion in walker 256 tumor-bearing rats. Front. Physiol. 2018, 9, 465. [CrossRef]166. Alves, C.R.R.; Neves, W.D.; de Almeida, N.R.; Eichelberger, E.J.; Jannig, P.R.; Voltarelli, V.A.; Tobias, G.C.; Bechara, L.R.G.; de Paula Faria, D.; Alves, M.J.N.; et al. Exercise training reverses cancer-induced oxidative stress and decrease in muscle COPS2/TRIP15/ALIEN. Mol. Metab. 2020, 39, 101012. [CrossRef] [PubMed]167. Grande, A.J.; Silva, V.; Sawaris Neto, L.; Teixeira Basmage, J.P.; Peccin, M.S.; Maddocks, M. Exercise for cancer cachexia in adults. Cochrane Database Syst. Rev. 2021, 2021, CD010804. [CrossRef]168. Bordignon, C.; Dos Santos, B.S.; Rosa, D.D. Impact of cancer cachexia on cardiac and skeletal muscle: Role of exercise training. Cancers 2022, 14, 342. [CrossRef] [PubMed]169. Karlsen, T.; Aamot, I.L.; Haykowsky, M.; Rognmo, Ø. High intensity interval training for maximizing health outcomes. Prog. Cardiovasc. Dis. 2017, 60, 67–77. [CrossRef]170. Rodriguez, A.L.; Whitehurst, M.; Fico, B.G.; Dodge, K.M.; Ferrandi, P.J.; Pena, G.; Adelman, A.; Huang, C.J. Acute high-intensity interval exercise induces greater levels of serum brain-derived neurotrophic factor in obese individuals. Exp. Biol. Med. 2018, 243, 1153–1160. [CrossRef] [PubMed]171. Papadopoulos, E.; Santa Mina, D. Can we HIIT cancer if we attack inflammation? Cancer Causes Control 2018, 29, 7–11. [CrossRef]172. O’Donovan, G.; Lee, I.M.; Hamer, M.; Stamatakis, E. Association of “weekend warrior” and other leisure time physical activity patterns with risks for all-cause, cardiovascular disease, and cancer mortality. JAMA Intern. Med. 2017, 177, 335–342. [CrossRef]173. Callahan, M.J.; Parr, E.B.; Hawley, J.A.; Camera, D.M. Can High-Intensity Interval Training Promote Skeletal Muscle Anabolism? Sports Med. 2021, 51, 405–421. [CrossRef]174. Ahmadabadi, F.; Saghebjoo, M.; Huang, C.J.; Saffari, I.; Zardast, M. The effects of high-intensity interval training and saffron aqueous extract supplementation on alterations of body weight and apoptotic indices in skeletal muscle of 4T1 breast cancerbearing mice with cachexia. Appl. Physiol. Nutr. Metab. 2020, 45, 555–563. [CrossRef]175. Ahmadabadi, F.; Saghebjoo, M.; Hoshyar, R. Decreased Liver Tissue Wasting following High-Intensity Interval Training through Apoptosis Signaling Suppression in Breast Tumor–Bearing Female Mice. Iran. Q. J. Breast Dis. 2020, 13, 49–58. [CrossRef]176. Alves, C.R.R.; da Cunha, T.F.; da Paixão, N.A.; Brum, P.C. Aerobic exercise training as therapy for cardiac and cancer cachexia. Life Sci. 2015, 125, 9–14. [CrossRef] [PubMed]177. Niels, T.; Tomanek, A.; Schneider, L.; Hasan, I.; Hallek, M.; Baumann, F.T. Exercise improves patient outcomes in advanced pancreatic cancer patient during medical treatment. Pancreat. Disord. Ther. 2018, 8, 193. [CrossRef]178. Klika, R.J.; Stafford, L.H. Exercise Oncology: High-Intensity Interval Training for Cancer Survivors. ACSM’s Health Fit. J. 2021, 25, 44–53. [CrossRef]179. Phillips, S.M.; Winett, R.A. Uncomplicated resistance training and health-related outcomes: Evidence for a public health mandate. Curr. Sports Med. Rep. 2010, 9, 208–213. [CrossRef] [PubMed]180. Mavropalias, G.; Sim, M.; Taaffe, D.R.; Galvão, D.A.; Spry, N.; Kraemer, W.J.; Häkkinen, K.; Newton, R.U. Exercise medicine for cancer cachexia: Targeted exercise to counteract mechanisms and treatment side effects. J. Cancer Res. Clin. Oncol. 2022. [CrossRef]181. Goodman, C.A.; Frey, J.W.; Mabrey, D.M.; Jacobs, B.L.; Lincoln, H.C.; You, J.S.; Hornberger, T.A. The role of skeletal muscle mTOR in the regulation of mechanical load-induced growth. J. Physiol. 2011, 589 Pt 22, 5485–5501. [CrossRef] [PubMed]182. Aquila, G.; Re Cecconi, A.D.; Brault, J.J.; Corli, O.; Piccirillo, R. Nutraceuticals and exercise against muscle wasting during cancer cachexia. Cells 2020, 9, 2536. [CrossRef]183. Donatto, F.F.; Neves, R.X.; Rosa, F.O.; Camargo, R.G.; Ribeiro, H.; Matos-Neto, E.M.; Seelaender, M. Resistance exercise modulates lipid plasma profile and cytokine content in the adipose tissue of tumour-bearing rats. Cytokine 2013, 61, 426–432. [CrossRef]184. Capozzi, L.C.; McNeely, M.L.; Lau, H.Y.; Reimer, R.A.; Giese-Davis, J.; Fung, T.S.; Culos-Reed, S.N. Patient-reported outcomes, body composition, and nutrition status in patients with head and neck cancer: Results from an exploratory randomized controlled exercise trial. Cancer 2016, 122, 1185–1200. [CrossRef]185. Newton, R.U.; Galvão, D.A.; Spry, N.; Joseph, D.; Chambers, S.K.; Gardiner, R.A.; Wall, B.A.; Bolam, K.A.; Taaffe, D.R. Exercise mode specificity for preserving spine and hip bone mineral density in prostate cancer patients. Med. Sci. Sports Exerc. 2019, 51, 607–614. [CrossRef]186. Wilson, J.M.; Marin, P.J.; Rhea, M.R.; Wilson, S.M.C.; Loenneke, J.P.; Anderson, J.C. Concurrent training: A meta-analysis examining interference of aerobic and resistance exercises. J. Strength Cond. Res. 2012, 26, 2293–2307. [CrossRef] [PubMed]187. Repka, C.P.; Hayward, R. Oxidative stress and fitness changes in cancer patients after exercise training. Med. Sci. Sports Exerc. 2016, 48, 607–614. [CrossRef] [PubMed]188. Galvão, D.A.; Taaffe, D.R.; Spry, N.; Joseph, D.; Newton, R.U. Combined resistance and aerobic exercise program reverses muscle loss in men undergoing androgen suppression therapy for prostate cancer without bone metastases: A randomized controlled trial. J. Clin. Oncol. 2010, 28, 340–347. [CrossRef]189. Schink, K.; Gaßner, H.; Reljic, D.; Herrmann, H.J.; Kemmler, W.; Schwappacher, R.; Meyer, J.; Eskofier, B.M.; Winkler, J.; Neurath, M.F.; et al. Assessment of gait parameters and physical function in patients with advanced cancer participating in a 12-week exercise and nutrition programme: A controlled clinical trial. Eur. J. Cancer Care 2020, 29, e13199. [CrossRef] [PubMed]190. Lønbro, S.; Dalgas, U.; Primdahl, H.; Johansen, J.; Nielsen, J.L.; Aagaard, P.; Hermann, A.P.; Overgaard, J.; Overgaard, K. Progressive resistance training rebuilds lean body mass in head and neck cancer patients after radiotherapy—Results from the randomized DAHANCA 25B trial. Radiother. Oncol. 2013, 108, 314–319. [CrossRef]191. Kamel, F.A.H.; Basha, M.A.; Alsharidah, A.S.; Salama, A.B. Resistance training impact on mobility, muscle strength and lean mass in pancreatic cancer cachexia: A randomized controlled trial. Clin. Rehabil. 2020, 34, 1391–1399. [CrossRef]192. Lavín-Pérez, A.M.; Collado-Mateo, D.; Mayo, X.; Liguori, G.; Humphreys, L.; Copeland, R.J.; Jiménez, A. Effects of high-intensity training on the quality of life of cancer patients and survivors: A systematic review with meta-analysis. Sci. Rep. 2021, 11, 15089. [CrossRef] [PubMed]193. Plotnikoff, R.C.; Courneya, K.S.; Trinh, L.; Karunamuni, N.; Sigal, R.J. Aerobic physical activity and resistance training: An application of the theory of planned behavior among adults with type 2 diabetes in a random, national sample of Canadians. Int. J. Behav. Nutr. Phys. Act. 2008, 5, 61. [CrossRef]194. Cormie, P.; Pumpa, K.; Galvão, D.A.; Turner, E.; Spry, N.; Saunders, C.; Zissiadis, Y.; Newton, R.U. Is it safe and efficacious for women with lymphedema secondary to breast cancer to lift heavy weights during exercise: A randomised controlled trial. J. Cancer Surviv. 2013, 7, 413–424. [CrossRef]195. Pedersen, B.K.; Saltin, B. Exercise as medicine—Evidence for prescribing exercise as therapy in 26 different chronic diseases. Scand. J. Med. Sci. Sport. 2015, 25, 1–72. [CrossRef]196. Del Fabbro, E.; Orr, T.A.; Stella, S.M. Practical approaches to managing cancer patients with weight loss. Curr. Opin. Support. Palliat. Care 2017, 11, 272–277. [CrossRef] [PubMed]197. Schmitt, J.; Lindner, N.; Reuss-Borst, M.; Holmberg, H.C.; Sperlich, B. A 3-week multimodal intervention involving high-intensity interval training in female cancer survivors: A randomized controlled trial. Physiol. Rep. 2016, 4, e12693. [CrossRef] [PubMed]198. Adamsen, L.; Quist, M.; Andersen, C.; Møller, T.; Herrstedt, J.; Kronborg, D.; Baadsgaard, M.T.; Vistisen, K.; Midtgaard, J.; Christiansen, B.; et al. Effect of a multimodal high intensity exercise intervention in cancer patients undergoing chemotherapy: Randomised controlled trial. BMJ 2009, 339, b3410. [CrossRef]199. Midtgaard, J.; Christensen, J.F.; Tolver, A.; Jones, L.W.; Uth, J.; Rasmussen, B.; Tang, L.; Adamsen, L.; Rørth, M. Efficacy of multimodal exercise-based rehabilitation on physical activity, cardiorespiratory fitness, and patient-reported outcomes in cancer survivors: A randomized, controlled trial. Ann. Oncol. 2013, 24, 2267–2273. [CrossRef]200. Redondo-Flórez, L.; Ramos-Campo, D.J.; Clemente-Suárez, V.J. Body Composition, Psychological, Cardiovascular, and Physical Activity Factors Related with Academic School Performance. Sustainability 2021, 13, 8775. [CrossRef]271819CachexiaCancerEndurance trainingErgonutritionalNutritionPhysical activityStrength trainingPublicationORIGINALNutritional and Exercise Interventions in Cancer-Related.pdfNutritional and Exercise Interventions in Cancer-Related.pdfArtículoapplication/pdf2180927https://repositorio.cuc.edu.co/bitstreams/28049696-6581-4500-abe3-bec2d20cf4de/download09db0739bf38d7f81203f36b1a75c848MD51LICENSElicense.txtlicense.txttext/plain; charset=utf-814828https://repositorio.cuc.edu.co/bitstreams/d91723b8-ba14-40cc-ac6c-7f148e068309/download2f9959eaf5b71fae44bbf9ec84150c7aMD52TEXTNutritional and Exercise Interventions in Cancer-Related.pdf.txtNutritional and Exercise Interventions in Cancer-Related.pdf.txtExtracted texttext/plain132429https://repositorio.cuc.edu.co/bitstreams/f8ced719-183e-4c69-bf95-b050fc17ef30/download3ff1a4e36907439d1a8a063b475ecbddMD53THUMBNAILNutritional and Exercise Interventions in Cancer-Related.pdf.jpgNutritional and Exercise Interventions in Cancer-Related.pdf.jpgGenerated Thumbnailimage/jpeg15909https://repositorio.cuc.edu.co/bitstreams/f550f9f2-9d71-4abc-996c-45b19b5d35a2/download20735c01399b38654d6a50aec0e31ee2MD5411323/10942oai:repositorio.cuc.edu.co:11323/109422024-09-17 14:12:28.321https://creativecommons.org/licenses/by/4.0/Copyright 2022 Elsevier B.V., All rights reserved.open.accesshttps://repositorio.cuc.edu.coRepositorio de la Universidad de la Costa CUCrepdigital@cuc.edu.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

Nutritional and exercise interventions in cancer-related cachexia: an extensive narrative review

Publicaciones similares